{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:31:53Z","timestamp":1790299913361,"version":"4.1.0"},"reference-count":277,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Emerging evidence suggest that dimethylbiguanide (metformin), a first-line drug for type 2 diabetes mellitus, could be neuroprotective in a range of brain pathologies, which include neurodegenerative diseases and brain injury. However, there are also contraindications that associate metformin treatment with cognitive impairment as well as adverse outcomes in Alzheimer\u2019s disease and Parkinson\u2019s disease animal models. Recently, a beneficial effect of metformin in animal models of Huntington\u2019s disease (HD) has been strengthened by multiple reports. In this brief review, the findings associated with the effects of metformin in attenuating neurodegenerative diseases are discussed, focusing on HD-associated pathology and the potential underlying mechanisms highlighted by these studies. The mechanism of action of metformin is complex, and its therapeutic efficacy is therefore expected to be dependent on the disease context. The key metabolic pathways that are effectively affected by metformin, such as AMP-activated protein kinase activation, may be altered in the later decades of the human lifespan. In this regard, metformin may nonetheless be therapeutically useful for neurological diseases with early pathological onsets, such as HD.<\/jats:p>","DOI":"10.1515\/revneuro-2019-0072","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:03:08Z","timestamp":1574326988000},"page":"297-317","source":"Crossref","is-referenced-by-count":11,"title":["Could metformin be therapeutically useful in Huntington\u2019s disease?"],"prefix":"10.1515","volume":"31","author":[{"given":"Bor Luen","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Yong Loo Lin School of Medicine , National University Health System , Singapore 117596 , Singapore"},{"name":"NUS Graduate School for Integrative Sciences and Engineering , National University of Singapore, Medical Drive , Singapore 119077 , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"2022062616292444752_j_revneuro-2019-0072_ref_001_w2aab3b7c17b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Abd-Elrahman, K.S. and Ferguson, S.S.G. (2019). Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington\u2019s pathology in zQ175 mice. Mol. Brain 12, 35.","DOI":"10.1186\/s13041-019-0456-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_002_w2aab3b7c17b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Abd-Elrahman, K.S., Hamilton, A., Hutchinson, S.R., Liu, F., Russell, R.C., and Ferguson, S.S.G. (2017). mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease. Sci. Signal. 10, eaan6387. doi: 10.1126\/scisignal.aan6387.","DOI":"10.1126\/scisignal.aan6387"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_003_w2aab3b7c17b1b6b1ab2b1b3Aa","unstructured":"Abd-Elsameea, A.A., Moustaf, A.A., and Mohamed, A.M. (2014). Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia\/reperfusion. Eur. Rev. Med. Pharmacol. Sci. 18, 2387\u20132392."},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_004_w2aab3b7c17b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Ahmad, W. and Ebert, P.R. (2017). Metformin attenuates A\u03b2 pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. elegans model of Alzheimer\u2019s disease. Mol. Neurobiol. 54, 5427\u20135439.","DOI":"10.1007\/s12035-016-0085-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_005_w2aab3b7c17b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Mahmood, Z., Javed, A., Hashmi, S.N., Zerr, I., Zafar, S., and Zahid, S. (2017). Effect of metformin on adult hippocampal neurogenesis: comparison with donepezil and links to cognition. J. Mol. Neurosci. 62, 88\u201398.","DOI":"10.1007\/s12031-017-0915-z"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_006_w2aab3b7c17b1b6b1ab2b1b6Aa","unstructured":"Alagiakrishnan, K., Sankaralingam, S., Ghosh, M., Mereu, L., and Senior, P. (2013). Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer\u2019s disease. Discov. Med. 16, 277\u2013286."},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_007_w2aab3b7c17b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. (2016). 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 12, 459\u2013509.","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_008_w2aab3b7c17b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Anderson, K.A., Ribar, T.J., Lin, F., Noeldner, P.K., Green, M.F., Muehlbauer, M.J., Witters, L.A., Kemp, B.E., and Means, A.R. (2008). Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell. Metab. 7, 377\u2013388.","DOI":"10.1016\/j.cmet.2008.02.011"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_009_w2aab3b7c17b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Apostolidis, S.A., Rodr\u00edguez-Rodr\u00edguez, N., Su\u00e1rez-Fueyo, A., Dioufa, N., Ozcan, E., Crisp\u00edn, J.C., Tsokos, M.G., and Tsokos, G.C. (2016). Phosphatase PP2A is requisite for the function of regulatory T cells. Nat. Immunol. 17, 556\u2013564.","DOI":"10.1038\/ni.3390"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_010_w2aab3b7c17b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Aranda-Orgill\u00e9s, B., Trockenbacher, A., Winter, J., Aigner, J., K\u00f6hler, A., Jastrzebska, E., Stahl, J., M\u00fcller, E.C., Otto, A., Wanker, E.E., et al. (2008). The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex. Hum. Genet. 123, 163\u2013176.","DOI":"10.1007\/s00439-007-0456-6"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_011_w2aab3b7c17b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Arbel\u00e1ez-Quintero, I. and Palacios, M. (2017). To use or not to use metformin in cerebral ischemia: a review of the application of metformin in stroke rodents. Stroke Res. Treat. 2017, 9756429.","DOI":"10.1155\/2017\/9756429"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_012_w2aab3b7c17b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Arnoux, I., Willam, M., Griesche, N., Krummeich, J., Watari, H., Offermann, N., Weber, S., Narayan Dey, P., Chen, C., Monteiro, O., et al. (2018). Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease. eLife 7, e38744.","DOI":"10.7554\/eLife.38744"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_013_w2aab3b7c17b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Arteaga-Bracho, E.E., Gulinello, M., Winchester, M.L., Pichamoorthy, N., Petronglo, J.R., Zambrano, A.D., Inocencio, J., De Jesus, C.D., Louie, J.O., Gokhan, S., et al. (2016). Postnatal and adult consequences of loss of huntingtin during development: implications for Huntington\u2019s disease. Neurobiol. Dis. 96, 144\u2013155.","DOI":"10.1016\/j.nbd.2016.09.006"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_014_w2aab3b7c17b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Asadbegi, M., Yaghmaei, P., Salehi, I., Ebrahim-Habibi, A., and Komaki, A. (2016). Neuroprotective effects of metformin against A\u03b2-mediated inhibition of long-term potentiation in rats fed a high-fat diet. Brain Res. Bull. 121, 178\u2013185.","DOI":"10.1016\/j.brainresbull.2016.02.005"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_015_w2aab3b7c17b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Ashabi, G., Khalaj, L., Khodagholi, F., Goudarzvand, M., and Sarkaki, A. (2015). Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab. Brain Dis. 30, 747\u2013754.","DOI":"10.1007\/s11011-014-9632-2"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_016_w2aab3b7c17b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Ashkenazi, A., Bento, C.F., Ricketts, T., Vicinanza, M., Siddiqi, F., Pavel, M., Squitieri, F., Hardenberg, M.C., Imarisio, S., Menzies, F.M., et al. (2017). Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545, 108\u2013111.","DOI":"10.1038\/nature22078"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_017_w2aab3b7c17b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Ba\u00f1ez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., Guzm\u00e1n, M., Estivill, X., and Mart\u00ed, E. (2012). A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet. 8, e1002481.","DOI":"10.1371\/journal.pgen.1002481"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_018_w2aab3b7c17b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., and Gasparini, L. (2016). Metformin promotes \u03c4 aggregation and exacerbates abnormal behavior in a mouse model of tauopathy. Mol. Neurodegener. 11, 16.","DOI":"10.1186\/s13024-016-0082-7"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_019_w2aab3b7c17b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Bar-Yosef, T., Damri, O., and Agam, G. (2019). Dual role of autophagy in diseases of the central nervous system. Front. Cell. Neurosci. 13, 196.","DOI":"10.3389\/fncel.2019.00196"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_020_w2aab3b7c17b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Bates, G.P., Dorsey, R., Gusella, J.F., Hayden, M.R., Kay, C., Leavitt, B.R., Nance, M., Ross, C.A., Scahill, R.I., Wetzel, R., et al. (2015). Huntington disease. Nat. Rev. Dis. Primers. 1, 15005.","DOI":"10.1038\/nrdp.2015.5"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_021_w2aab3b7c17b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Bayliss, J.A., Lemus, M.B., Santos, V.V., Deo, M., Davies, J.S., Kemp, B.E., Elsworth, J.D., and Andrews, Z.B. (2016). Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons. PLoS One 11, e0159381.","DOI":"10.1371\/journal.pone.0159381"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_022_w2aab3b7c17b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.F., Giorgetti-Peraldi, S., and Bost, F. (2011). Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 71, 4366\u20134372.","DOI":"10.1158\/0008-5472.CAN-10-1769"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_023_w2aab3b7c17b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Berthier, A., Pay\u00e1, M., Garc\u00eda-Cabrero, A.M., Ballester, M.I., Heredia, M., Serratosa, J.M., S\u00e1nchez, M.P., and Sanz, P. (2016). Pharmacological interventions to ameliorate neuropathological symptoms in a mouse model of Lafora disease. Mol. Neurobiol. 53, 1296\u20131309.","DOI":"10.1007\/s12035-015-9091-8"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_024_w2aab3b7c17b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Bharadwaj, P., Wijesekara, N., Liyanapathirana, M., Newsholme, P., Ittner, L., Fraser, P., and Verdile, G. (2017). The link between type 2 diabetes and neurodegeneration: roles for amyloid-\u03b2, amylin, and \u03c4 proteins. J. Alzheimers Dis. 59, 421\u2013432.","DOI":"10.3233\/JAD-161192"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_025_w2aab3b7c17b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Bialik, S., Dasari, S.K., and Kimchi, A. (2018). Autophagy-dependent cell death \u2013 where, how and why a cell eats itself to death. J. Cell. Sci. 131, pii: jcs215152. doi: 10.1242\/jcs.215152.","DOI":"10.1242\/jcs.215152"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_026_w2aab3b7c17b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Biosa, A., Outeiro, T.F., Bubacco, L., and Bisaglia, M. (2018). Diabetes mellitus as a risk factor for Parkinson\u2019s disease: a molecular point of view. Mol. Neurobiol. 55, 8754\u20138763.","DOI":"10.1007\/s12035-018-1025-9"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_027_w2aab3b7c17b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Bisulli, F., Muccioli, L., d\u2019Orsi, G., Canafoglia, L., Freri, E., Licchetta, L., Mostacci, B., Riguzzi, P., Pondrelli, F., Avolio, C., et al. (2019). Treatment with metformin in twelve patients with Lafora disease. Orphanet. J. Rare Dis. 14, 149.","DOI":"10.1186\/s13023-019-1132-3"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_028_w2aab3b7c17b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Brakedal, B., Fl\u00f8nes, I., Reiter, S.F., Torkildsen, \u00d8., D\u00f6lle, C., Assmus, J., Haugarvoll, K., and Tzoulis, C. (2017). Glitazone use associated with reduced risk of Parkinson\u2019s disease. Mov. Disord. 32, 1594\u20131599.","DOI":"10.1002\/mds.27128"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_029_w2aab3b7c17b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Burkewitz, K., Zhang, Y., and Mair, W.B. (2014). AMPK at the nexus of energetics and aging. Cell. Metab. 20, 10\u201325.","DOI":"10.1016\/j.cmet.2014.03.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_030_w2aab3b7c17b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Burrows, D.J., McGown, A., Jain, S.A., De Felice, M., Ramesh, T.M., Sharrack, B., and Majid, A. (2019). Animal models of multiple sclerosis: from rodents to zebrafish. Mult. Scler. 25, 306\u2013324.","DOI":"10.1177\/1352458518805246"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_031_w2aab3b7c17b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Byrne, F.M., Cheetham, S., Vickers, S., and Chapman, V. (2015). Characterisation of pain responses in the high fat diet\/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments. J. Diabetes Res. 2015, 752481.","DOI":"10.1155\/2015\/752481"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_032_w2aab3b7c17b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Campbell, J.M., Stephenson, M.D., de Courten, B., Chapman, I., Bellman, S.M., and Aromataris, E. (2018). Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis. J. Alzheimers Dis. 65, 1225\u20131236.","DOI":"10.3233\/JAD-180263"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_033_w2aab3b7c17b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Canals, J.M., Pineda, J.R., Torres-Peraza, J.F., Bosch, M., Mart\u00edn-Iba\u00f1ez, R., Mu\u00f1oz, M.T., Mengod, G., Ernfors, P., and Alberch, J. (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J. Neurosci. 24, 7727\u20137739.","DOI":"10.1523\/JNEUROSCI.1197-04.2004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_034_w2aab3b7c17b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Caron, N.S., Dorsey, E.R., and Hayden, M.R. (2018). Therapeutic approaches to Huntington disease: from the bench to the clinic. Nat. Rev. Drug Discov. 17, 729\u2013750.","DOI":"10.1038\/nrd.2018.133"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_035_w2aab3b7c17b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Chang, J., Jung, H.H., Yang, J.Y., Lee, S., Choi, J., Im, G.J., and Chae, S.W. (2014). Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line. J. Assoc. Res. Otolaryngol. 15, 149\u2013158.","DOI":"10.1007\/s10162-013-0431-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_036_w2aab3b7c17b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Chatterjee, S. and Mudher, A. (2018). Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits. Front. Neurosci. 12, 383.","DOI":"10.3389\/fnins.2018.00383"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_037_w2aab3b7c17b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.D., Ma, T., Thompson, R.C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009). Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer\u2019s amyloid peptides via up-regulating BACE1 transcription. Proc. Natl. Acad. Sci. U.S.A. 106, 3907\u20133912.","DOI":"10.1073\/pnas.0807991106"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_038_w2aab3b7c17b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Chen, J.L., Luo, C., Pu, D., Zhang, G.Q., Zhao, Y.X., Sun, Y., Zhao, K.X., Liao, Z.Y., Lv, A.K., Zhu, S.Y., et al. (2019). Metformin attenuates diabetes-induced \u03c4 hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance. Exp. Neurol. 311, 44\u201356.","DOI":"10.1016\/j.expneurol.2018.09.008"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_039_w2aab3b7c17b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Cheng, Y.Y., Leu, H.B., Chen, T.J., Chen, C.L., Kuo, C.H., Lee, S.D., and Kao, C.L. (2014). Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. J. Stroke Cerebrovasc. Dis. 23, e99\u2013e105.","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.09.001"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_040_w2aab3b7c17b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Chiang, M.C., Cheng, Y.C., Chen, S.J., Yen, C.H., and Huang, R.N. (2016). Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-\u03b2-induced mitochondrial dysfunction. Exp. Cell. Res. 347, 322\u2013331.","DOI":"10.1016\/j.yexcr.2016.08.013"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_041_w2aab3b7c17b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Chung, M.M., Nicol, C.J., Cheng, Y.C., Lin, K.H., Chen, Y.L., Pei, D., Lin, C.H., Shih, Y.N., Yen, C.H., Chen, S.J., et al. (2017). Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. Exp. Cell. Res. 352, 75\u201383.","DOI":"10.1016\/j.yexcr.2017.01.017"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_042_w2aab3b7c17b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Clarke, J.R., Ribeiro, F.C., Frozza, R.L., De Felice, F.G., and Lourenco, M.V. (2018). Metabolic dysfunction in Alzheimer\u2019s disease: from basic neurobiology to clinical approaches. J. Alzheimers Dis. 64, S405\u2013S426.","DOI":"10.3233\/JAD-179911"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_043_w2aab3b7c17b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"Croce, K.R. and Yamamoto, A. (2019). A role for autophagy in Huntington\u2019s disease. Neurobiol. Dis. 122, 16\u201322.","DOI":"10.1016\/j.nbd.2018.08.010"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_044_w2aab3b7c17b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"Crotti, A. and Glass, C.K. (2015). The choreography of neuroinflammation in Huntington\u2019s disease. Trends Immunol. 36, 364\u2013373.","DOI":"10.1016\/j.it.2015.04.007"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_045_w2aab3b7c17b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Crotti, A., Benner, C., Kerman, B.E., Gosselin, D., Lagier-Tourenne, C., Zuccato, C., Cattaneo, E., Gage, F.H., Cleveland, D.W., and Glass, C.K. (2014). Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat. Neurosci. 17, 513\u2013521.","DOI":"10.1038\/nn.3668"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_046_w2aab3b7c17b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Curry, D.W., Stutz, B., Andrews, Z.B., and Elsworth, J.D. (2018). Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease. J. Parkinsons Dis. 8, 161\u2013181.","DOI":"10.3233\/JPD-171296"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_047_w2aab3b7c17b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"Dadwal, P., Mahmud, N., Sinai, L., Azimi, A., Fatt, M., Wondisford, F.E., Miller, F.D., and Morshead, C.M. (2015). Activating endogenous neural precursor cells using Metformin leads to neural repair and functional recovery in a model of childhood brain injury. Stem Cell Rep. 5, 166\u2013173.","DOI":"10.1016\/j.stemcr.2015.06.011"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_048_w2aab3b7c17b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"Demir, U., Koehler, A., Schneider, R., Schweiger, S., and Klocker, H. (2014). Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. BMC Cancer 14, 52.","DOI":"10.1186\/1471-2407-14-52"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_049_w2aab3b7c17b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"Denton, D. and Kumar, S. (2019). Autophagy-dependent cell death. Cell Death Differ. 26, 605\u2013616.","DOI":"10.1038\/s41418-018-0252-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_050_w2aab3b7c17b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"DeYoung, M.P., Horak, P., Sofer, A., Sgroi, D., and Ellisen, L.W. (2008). Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22, 239\u2013251.","DOI":"10.1101\/gad.1617608"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_051_w2aab3b7c17b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"DiTacchio, K.A., Heinemann, S.F., and Dziewczapolski, G. (2015). Metformin treatment alters memory function in a mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 44, 43\u201348.","DOI":"10.3233\/JAD-141332"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_052_w2aab3b7c17b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Domise, M., Sauv\u00e9, F., Didier, S., Caillerez, R., B\u00e9gard, S., Carrier, S., Colin, M., Marinangeli, C., Bu\u00e9e, L., and Vingtdeux, V. (2019). Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process. Cell Death Dis. 10, 221.","DOI":"10.1038\/s41419-019-1464-x"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_053_w2aab3b7c17b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"Dragatsis, I., Levine, M.S., and Zeitlin, S. (2000). Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26, 300\u2013306.","DOI":"10.1038\/81593"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_054_w2aab3b7c17b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.J., and Mattson, M.P. (2003). Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. U.S.A. 100, 2911\u20132916.","DOI":"10.1073\/pnas.0536856100"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_055_w2aab3b7c17b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Dulovic, M., Jovanovic, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L., Kravic-Stevovic, T., Paunovic, V., Ardah, M.T., El-Agnaf, O.M.A., Kostic, V., et al. (2014). The protective role of AMP-activated protein kinase in \u03b1-synuclein neurotoxicity in vitro. Neurobiol. Dis. 63, 1\u201311.","DOI":"10.1016\/j.nbd.2013.11.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_056_w2aab3b7c17b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F., and Joyner, A.L. (1995). Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269, 407\u2013410.","DOI":"10.1126\/science.7618107"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_057_w2aab3b7c17b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"Dy, A.B.C., Tassone, F., Eldeeb, M., Salcedo-Arellano, M.J., Tartaglia, N., and Hagerman, R. (2018). Metformin as targeted treatment in fragile X syndrome. Clin. Genet. 93, 216\u2013222.","DOI":"10.1111\/cge.13039"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_058_w2aab3b7c17b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"Elbaz, A., Carcaillon, L., Kab, S., and Moisan, F. (2016). Epidemiology of Parkinson\u2019s disease. Rev. Neurol. (Paris) 172, 14\u201326.","DOI":"10.1016\/j.neurol.2015.09.012"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_059_w2aab3b7c17b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"El-Mir, M.Y., Nogueira, V., Fontaine, E., Av\u00e9ret, N., Rigoulet, M., and Leverve, X. (2000). Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223\u2013228.","DOI":"10.1074\/jbc.275.1.223"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_060_w2aab3b7c17b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"El-Mir, M.Y., Detaille, D., R-Villanueva, G., Delgado-Esteban, M., Guigas, B., Attia, S., Fontaine, E., Almeida, A., and Leverve, X. (2008). Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J. Mol. Neurosci. 34, 77\u201387.","DOI":"10.1007\/s12031-007-9002-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_061_w2aab3b7c17b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"Ettcheto, M., Cano, A., Busquets, O., Manzine, P.R., S\u00e1nchez-L\u00f3pez, E., Castro-Torres, R.D., Beas-Zarate, C., Verdaguer, E., Garc\u00eda, M.L., Olloquequi, J., et al. (2019). A metabolic perspective of late onset Alzheimer\u2019s disease. Pharmacol. Res. 145, 104255.","DOI":"10.1016\/j.phrs.2019.104255"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_062_w2aab3b7c17b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"Fan, J., Li, D., Chen, H.S., Huang, J.G., Xu, J.F., Zhu, W.W., Chen, J.G., and Wang, F. (2019). Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane. Br. J. Pharmacol. 176, 297\u2013316.","DOI":"10.1111\/bph.14519"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_063_w2aab3b7c17b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"Farina, F., Lambert, E., Commeau, L., Lejeune, F.X., Roudier, N., Fonte, C., Parker, J.A., Boddaert, J., Verny, M., Baulieu, E.E., et al. (2017). The stress response factor daf-16\/FOXO is required for multiple compound families to prolong the function of neurons with Huntington\u2019s disease. Sci. Rep. 7, 4014.","DOI":"10.1038\/s41598-017-04256-w"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_064_w2aab3b7c17b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"Farr, S.A., Roesler, E., Niehoff, M.L., Roby, D.A., McKee, A., and Morley, J.E. (2019). Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 68, 1699\u20131710.","DOI":"10.3233\/JAD-181240"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_065_w2aab3b7c17b1b6b1ab2b1c65Aa","doi-asserted-by":"crossref","unstructured":"Fatt, M., Hsu, K., He, L., Wondisford, F., Miller, F.D., Kaplan, D.R., and Wang, J. (2015). Metformin acts on two different molecular pathways to enhance adult neural precursor proliferation\/self-renewal and differentiation. Stem Cell Rep. 5, 988\u2013995.","DOI":"10.1016\/j.stemcr.2015.10.014"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_066_w2aab3b7c17b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M., and Viollet, B. (2014). Metformin: from mechanisms of action to therapies. Cell. Metab. 20, 953\u2013966.","DOI":"10.1016\/j.cmet.2014.09.018"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_067_w2aab3b7c17b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"Gafni, J., Hermel, E., Young, J.E., Wellington, C.L., Hayden, M.R., and Ellerby, L.M. (2004). Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus. J. Biol. Chem. 279, 20211\u201320220.","DOI":"10.1074\/jbc.M401267200"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_068_w2aab3b7c17b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"Galimberti, D. and Scarpini, E. (2017). Pioglitazone for the treatment of Alzheimer\u2019s disease. Expert Opin. Invest. Drugs 26, 97\u2013101.","DOI":"10.1080\/13543784.2017.1265504"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_069_w2aab3b7c17b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"Gantois, I., Khoutorsky, A., Popic, J., Aguilar-Valles, A., Freemantle, E., Cao, R., Sharma, V., Pooters, T., Nagpal, A., Skalecka, A., et al. (2017). Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat. Med. 23, 674\u2013677.","DOI":"10.1038\/nm.4335"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_070_w2aab3b7c17b1b6b1ab2b1c70Aa","doi-asserted-by":"crossref","unstructured":"Gantois, I., Popic, J., Khoutorsky, A., and Sonenberg, N. (2019).Metformin for treatment of fragile X syndrome and other neurological disorders. Annu. Rev. Med. 70, 167\u2013181.","DOI":"10.1146\/annurev-med-081117-041238"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_071_w2aab3b7c17b1b6b1ab2b1c71Aa","doi-asserted-by":"crossref","unstructured":"Ge, X.H., Zhu, G.J., Geng, D.Q., Zhang, H.Z., He, J.M., Guo, A.Z., Ma, L.L., and Yu, D.H. (2017). Metformin protects the brain against ischemia\/reperfusion injury through PI3K\/Akt1\/JNK3 signaling pathways in rats. Physiol. Behav. 170, 115\u2013123.","DOI":"10.1016\/j.physbeh.2016.12.021"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_072_w2aab3b7c17b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"Ghadernezhad, N., Khalaj, L., Pazoki-Toroudi, H., Mirmasoumi, M., and Ashabi, G. (2016). Metformin pretreatment enhanced learning and memory in cerebral forebrain ischaemia: the role of the AMPK\/BDNF\/P70SK signalling pathway. Pharm. Biol. 54, 2211\u20132219.","DOI":"10.3109\/13880209.2016.1150306"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_073_w2aab3b7c17b1b6b1ab2b1c73Aa","doi-asserted-by":"crossref","unstructured":"Gil, J.M. and Rego, A.C. (2009). The R6 lines of transgenic mice: a model for screening new therapies for Huntington\u2019s disease. Brain Res. Rev. 59, 410\u2013431.","DOI":"10.1016\/j.brainresrev.2008.12.001"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_074_w2aab3b7c17b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"Graham, R.K., Deng, Y., Slow, E.J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., et al. (2006). Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179\u20131191.","DOI":"10.1016\/j.cell.2006.04.026"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_075_w2aab3b7c17b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"Greer, E.L., Banko, M.R., and Brunet, A. (2009). AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Annu. N. Y. Acad. Sci. 1170, 688\u2013692.","DOI":"10.1111\/j.1749-6632.2009.04019.x"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_076_w2aab3b7c17b1b6b1ab2b1c76Aa","doi-asserted-by":"crossref","unstructured":"Griesche, N., Schilling, J., Weber, S., Rohm, M., Pesch, V., Matthes, F., Auburger, G., and Krauss, S. (2016). Regulation of mRNA translation by MID1: a common mechanism of expanded CAG repeat RNAs. Front. Cell. Neurosci. 10, 226.","DOI":"10.3389\/fncel.2016.00226"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_077_w2aab3b7c17b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"Guiney, S.J., Adlard, P.A., Bush, A.I., Finkelstein, D.I., and Ayton, S. (2017). Ferroptosis and cell death mechanisms in Parkinson\u2019s disease. Neurochem. Int. 104, 34\u201348.","DOI":"10.1016\/j.neuint.2017.01.004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_078_w2aab3b7c17b1b6b1ab2b1c78Aa","doi-asserted-by":"crossref","unstructured":"Guo, Y., Wang, F., Li, H., Liang, H., Li, Y., Gao, Z., and He, X. (2018). Metformin protects against spinal cord injury by regulating autophagy via the mTOR signaling pathway. Neurochem. Res. 43, 1111\u20131117.","DOI":"10.1007\/s11064-018-2525-8"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_079_w2aab3b7c17b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"Gupta, A., Bisht, B., and Dey, C.S. (2011). Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes. Neuropharmacology 60, 910\u2013920.","DOI":"10.1016\/j.neuropharm.2011.01.033"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_080_w2aab3b7c17b1b6b1ab2b1c80Aa","doi-asserted-by":"crossref","unstructured":"Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E., and Shaw, R.J. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226.","DOI":"10.1016\/j.molcel.2008.03.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_081_w2aab3b7c17b1b6b1ab2b1c81Aa","doi-asserted-by":"crossref","unstructured":"Hagerman, R.J., Berry-Kravis, E., Hazlett, H.C., Bailey, D.B., Moine, H., Kooy, R.F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J.L., et al. (2017). Fragile X syndrome. Nat. Rev. Dis. Primers 3, 17065.","DOI":"10.1038\/nrdp.2017.65"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_082_w2aab3b7c17b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"Hara, K., Maruki, Y., Long, X., Yoshino, K.I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., and Yonezawa, K. (2002). Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177\u2013189.","DOI":"10.1016\/S0092-8674(02)00833-4"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_083_w2aab3b7c17b1b6b1ab2b1c83Aa","doi-asserted-by":"crossref","unstructured":"Harada, S., Fujita-Hamabe, W., and Tokuyama, S. (2010). The importance of regulation of blood glucose levels through activation of peripheral 5\u2032-AMP-activated protein kinase on ischemic neuronal damage. Brain Res. 1351, 254\u2013263.","DOI":"10.1016\/j.brainres.2010.06.052"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_084_w2aab3b7c17b1b6b1ab2b1c84Aa","doi-asserted-by":"crossref","unstructured":"Hersch, S.M., Schifitto, G., Oakes, D., Bredlau, A.L., Meyers, C.M., Nahin, R., Rosas, H.D., and Huntington Study Group CREST-E Investigators and Coordinators. (2017). The CREST-E study of creatine for Huntington disease: a randomized controlled trial. Neurology 89, 594\u2013601.","DOI":"10.1212\/WNL.0000000000004209"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_085_w2aab3b7c17b1b6b1ab2b1c85Aa","doi-asserted-by":"crossref","unstructured":"Herv\u00e1s, D., Forn\u00e9s-Ferrer, V., G\u00f3mez-Escribano, A.P., Sequedo, M.D., Peir\u00f3, C., Mill\u00e1n, J.M., and V\u00e1zquez-Manrique, R.P. (2017). Metformin intake associates with better cognitive function in patients with Huntington\u2019s disease. PLoS One 12, e0179283.","DOI":"10.1371\/journal.pone.0179283"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_086_w2aab3b7c17b1b6b1ab2b1c86Aa","doi-asserted-by":"crossref","unstructured":"Hettich, M.M., Matthes, F., Ryan, D.P., Griesche, N., Schr\u00f6der, S., Dorn, S., Krau\u03b2, S., and Ehninger, D. (2014). The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex. PLoS One 9, e102420.","DOI":"10.1371\/journal.pone.0102420"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_087_w2aab3b7c17b1b6b1ab2b1c87Aa","doi-asserted-by":"crossref","unstructured":"Hill, J.L., Kobori, N., Zhao, J., Rozas, N.S., Hylin, M.J., Moore, A.N., and Dash, P.K. (2016). Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome. J. Neurochem. 139, 106\u2013119.","DOI":"10.1111\/jnc.13726"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_088_w2aab3b7c17b1b6b1ab2b1c88Aa","doi-asserted-by":"crossref","unstructured":"Hindupur, S.K., Gonz\u00e1lez, A., and Hall, M.N. (2015). The opposing actions of target of rapamycin and AMP-activated protein kinase in cell growth control. Cold Spring Harb. Perspect. Biol. 7, a019141.","DOI":"10.1101\/cshperspect.a019141"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_089_w2aab3b7c17b1b6b1ab2b1c89Aa","doi-asserted-by":"crossref","unstructured":"Hinz, M. and Scheidereit, C. (2014). The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 15, 46\u201361.","DOI":"10.1002\/embr.201337983"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_090_w2aab3b7c17b1b6b1ab2b1c90Aa","doi-asserted-by":"crossref","unstructured":"Hsiao, H.Y., Chen, Y.C., Chen, H.M., Tu, P.H., and Chern, Y. (2013). A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington\u2019s disease. Hum. Mol. Genet. 22, 1826\u20131842.","DOI":"10.1093\/hmg\/ddt036"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_091_w2aab3b7c17b1b6b1ab2b1c91Aa","doi-asserted-by":"crossref","unstructured":"Hunter, J., Rivero-Arias, O., Angelov, A., Kim, E., Fotheringham, I., and Leal, J. (2014). Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am. J. Med. Genet. A 164A, 1648\u20131658.","DOI":"10.1002\/ajmg.a.36511"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_092_w2aab3b7c17b1b6b1ab2b1c92Aa","doi-asserted-by":"crossref","unstructured":"Hussein, A.M., Eldosoky, M., El-Shafey, M., El-Mesery, M., Ali, A.N., Abbas, K.M., and Abulseoud, O.A. (2019). Effects of metformin on apoptosis and \u03b1-synuclein in a rat model of pentylenetetrazole-induced epilepsy. Can. J. Physiol. Pharmacol. 97, 37\u201346.","DOI":"10.1139\/cjpp-2018-0266"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_093_w2aab3b7c17b1b6b1ab2b1c93Aa","doi-asserted-by":"crossref","unstructured":"Hwang, I.K., Kim, I.Y., Joo, E.J., Shin, J.H., Choi, J.W., Won, M.H., Yoon, Y.S., and Seong, J.K. (2010). Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus. Neurochem. Res. 35, 645\u2013650.","DOI":"10.1007\/s11064-009-0115-5"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_094_w2aab3b7c17b1b6b1ab2b1c94Aa","doi-asserted-by":"crossref","unstructured":"Imfeld, P., Bodmer, M., Jick, S.S., and Meier, C.R. (2012). Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study. J. Am. Geriatr. Soc. 60, 916\u2013921.","DOI":"10.1111\/j.1532-5415.2012.03916.x"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_095_w2aab3b7c17b1b6b1ab2b1c95Aa","doi-asserted-by":"crossref","unstructured":"Inoki, K., Zhu, T., and Guan, K.L. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590.","DOI":"10.1016\/S0092-8674(03)00929-2"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_096_w2aab3b7c17b1b6b1ab2b1c96Aa","doi-asserted-by":"crossref","unstructured":"Ismaiel, A.A.K., Espinosa-Oliva, A.M., Santiago, M., Garc\u00eda-Quintanilla, A., Oliva-Mart\u00edn, M.J., Herrera, A.J., Venero, J.L., and de Pablos, R.M. (2016). Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system. Toxicol. Appl. Pharmacol. 298, 19\u201330.","DOI":"10.1016\/j.taap.2016.03.004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_097_w2aab3b7c17b1b6b1ab2b1c97Aa","doi-asserted-by":"crossref","unstructured":"Jia, J., Cheng, J., Ni, J., and Zhen, X. (2015). Neuropharmacological actions of metformin in stroke. Curr. Neuropharmacol. 13, 389\u2013394.","DOI":"10.2174\/1570159X13666150205143555"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_098_w2aab3b7c17b1b6b1ab2b1c98Aa","doi-asserted-by":"crossref","unstructured":"Jin, Q., Cheng, J., Liu, Y., Wu, J., Wang, X., Wei, S., Zhou, X., Qin, Z., Jia, J., and Zhen, X. (2014). Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia\/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain Behav. Immun. 40, 131\u2013142.","DOI":"10.1016\/j.bbi.2014.03.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_099_w2aab3b7c17b1b6b1ab2b1c99Aa","doi-asserted-by":"crossref","unstructured":"Jin, J., Gu, H., Anders, N.M., Ren, T., Jiang, M., Tao, M., Peng, Q., Rudek, M.A., and Duan, W. (2016). Metformin protects cells from mutant Huntingtin toxicity through activation of AMPK and modulation of mitochondrial dynamics. Neuromol. Med. 18, 581\u2013592.","DOI":"10.1007\/s12017-016-8412-z"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_100_w2aab3b7c17b1b6b1ab2b1d100Aa","doi-asserted-by":"crossref","unstructured":"Joseph, B.K., Liu, H.Y., Francisco, J., Pandya, D., Donigan, M., Gallo-Ebert, C., Giordano, C., Bata, A., and Nickels, J.T. (2015). Inhibition of AMP kinase by the protein phosphatase 2A heterotrimer, PP2APpp2r2d. J. Biol. Chem. 290, 10588\u201310598.","DOI":"10.1074\/jbc.M114.626259"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_101_w2aab3b7c17b1b6b1ab2b1d101Aa","doi-asserted-by":"crossref","unstructured":"Ju, T.C., Chen, H.M., Lin, J.T., Chang, C.P., Chang, W.C., Kang, J.J., Sun, C.P., Tao, M.H., Tu, P.H., Chang, C., et al. (2011). Nuclear translocation of AMPK-\u03b11 potentiates striatal neurodegeneration in Huntington\u2019s disease. J. Cell. Biol. 194, 209\u2013227.","DOI":"10.1083\/jcb.201105010"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_102_w2aab3b7c17b1b6b1ab2b1d102Aa","doi-asserted-by":"crossref","unstructured":"Ju, T.C., Chen, H.M., Chen, Y.C., Chang, C.P., Chang, C., and Chern, Y. (2014). AMPK-\u03b11 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington\u2019s disease. Biochim. Biophys. Acta 1842, 1668\u20131680.","DOI":"10.1016\/j.bbadis.2014.06.012"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_103_w2aab3b7c17b1b6b1ab2b1d103Aa","doi-asserted-by":"crossref","unstructured":"Kalender, A., Selvaraj, A., Kim, S.Y., Gulati, P., Br\u00fbl\u00e9, S., Viollet, B., Kemp, B.E., Bardeesy, N., Dennis, P., Schlager, J.J., et al. (2010). Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell. Metab. 11, 390\u2013401.","DOI":"10.1016\/j.cmet.2010.03.014"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_104_w2aab3b7c17b1b6b1ab2b1d104Aa","doi-asserted-by":"crossref","unstructured":"Kaneb, H.M., Sharp, P.S., Rahmani-Kondori, N., and Wells, D.J. (2011). Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS One 6, e24189.","DOI":"10.1371\/journal.pone.0024189"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_105_w2aab3b7c17b1b6b1ab2b1d105Aa","doi-asserted-by":"crossref","unstructured":"Kang, H., Khang, R., Ham, S., Jeong, G.R., Kim, H., Jo, M., Lee, B.D., Lee, Y.I., Jo, A., Park, C., et al. (2017a). Activation of the ATF2\/CREB-PGC-1\u03b1 pathway by metformin leads to dopaminergic neuroprotection. Oncotarget 8, 48603\u201348618.","DOI":"10.18632\/oncotarget.18122"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_106_w2aab3b7c17b1b6b1ab2b1d106Aa","doi-asserted-by":"crossref","unstructured":"Kang, S.S., Zhang, Z., Liu, X., Manfredsson, F.P., He, L., Iuvone, P.M., Cao, X., Sun, Y.E., Jin, L., and Ye, K. (2017b). \u03b1-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation. Proc. Natl. Acad. Sci. U.S.A. 114, 1183\u20131188.","DOI":"10.1073\/pnas.1618627114"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_107_w2aab3b7c17b1b6b1ab2b1d107Aa","doi-asserted-by":"crossref","unstructured":"Katic, M. and Kahn, C.R. (2005). The role of insulin and IGF-1 signaling in longevity. Cell. Mol. Life Sci. 62, 320\u2013343.","DOI":"10.1007\/s00018-004-4297-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_108_w2aab3b7c17b1b6b1ab2b1d108Aa","doi-asserted-by":"crossref","unstructured":"Katila, N., Bhurtel, S., Shadfar, S., Srivastav, S., Neupane, S., Ojha, U., Jeong, G.S., and Choi, D.Y. (2017). Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease.Neuropharmacology 125, 396\u2013407.","DOI":"10.1016\/j.neuropharm.2017.08.015"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_109_w2aab3b7c17b1b6b1ab2b1d109Aa","doi-asserted-by":"crossref","unstructured":"Kazyken, D., Magnuson, B., Bodur, C., Acosta-Jaquez, H.A., Zhang, D., Tong, X., Barnes, T.M., Steinl, G.K., Patterson, N.E., Altheim, C.H., et al. (2019). AMPK directly activates mTORC2 to promote cell survival during acute energetic stress. Sci. Signal. 12, pii: eaav3249. doi: 10.1126\/scisignal.aav3249.","DOI":"10.1126\/scisignal.aav3249"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_110_w2aab3b7c17b1b6b1ab2b1d110Aa","doi-asserted-by":"crossref","unstructured":"Khoshnan, A., Ko, J., Watkin, E.E., Paige, L.A., Reinhart, P.H., and Patterson, P.H. (2004). Activation of the I\u03baB kinase complex and nuclear factor-\u03baB contributes to mutant huntingtin neurotoxicity. J. Neurosci. 24, 7999\u20138008.","DOI":"10.1523\/JNEUROSCI.2675-04.2004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_111_w2aab3b7c17b1b6b1ab2b1d111Aa","doi-asserted-by":"crossref","unstructured":"Khoshnan, A., Sabbaugh, A., Calamini, B., Marinero, S.A., Dunn, D.E., Yoo, J.H., Ko, J., Lo, D.C., and Patterson, P.H. (2017). IKK\u03b2 and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD. Hum. Mol. Genet. 26, 4267\u20134277.","DOI":"10.1093\/hmg\/ddx315"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_112_w2aab3b7c17b1b6b1ab2b1d112Aa","doi-asserted-by":"crossref","unstructured":"Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., K\u00f6hler, A., Glossmann, H., et al. (2010). Biguanide metformin acts on \u03c4 phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. U.S.A. 107, 21830\u201321835.","DOI":"10.1073\/pnas.0912793107"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_113_w2aab3b7c17b1b6b1ab2b1d113Aa","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K.B., Qin, Z.H., Aronin, N., and DiFiglia, M. (2001). Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. U.S.A. 98, 12784\u201312789.","DOI":"10.1073\/pnas.221451398"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_114_w2aab3b7c17b1b6b1ab2b1d114Aa","doi-asserted-by":"crossref","unstructured":"Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D.M. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163\u2013175.","DOI":"10.1016\/S0092-8674(02)00808-5"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_115_w2aab3b7c17b1b6b1ab2b1d115Aa","doi-asserted-by":"crossref","unstructured":"Kim, M., Roh, J.K., Yoon, B.W., Kang, L., Kim, Y.J., Aronin, N., and DiFiglia, M. (2003). Huntingtin is degraded to small fragments by calpain after ischemic injury. Exp. Neurol. 183, 109\u2013115.","DOI":"10.1016\/S0014-4886(03)00132-8"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_116_w2aab3b7c17b1b6b1ab2b1d116Aa","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Sapp, E., Cuiffo, B.G., Sobin, L., Yoder, J., Kegel, K.B., Qin, Z.H., Detloff, P., Aronin, N., and DiFiglia, M. (2006). Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol. Dis. 22, 346\u2013356.","DOI":"10.1016\/j.nbd.2005.11.012"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_117_w2aab3b7c17b1b6b1ab2b1d117Aa","doi-asserted-by":"crossref","unstructured":"Kim, D.H., Park, M.H., Lee, E.K., Choi, Y.J., Chung, K.W., Moon, K.M., Kim, M.J., An, H.J., Park, J.W., Kim, N.D., et al. (2015). The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology 16, 1\u201314.","DOI":"10.1007\/s10522-014-9519-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_118_w2aab3b7c17b1b6b1ab2b1d118Aa","doi-asserted-by":"crossref","unstructured":"King, M.A., Hands, S., Hafiz, F., Mizushima, N., Tolkovsky, A.M., and Wyttenbach, A. (2008). Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol. Pharmacol. 73, 1052\u20131063.","DOI":"10.1124\/mol.107.043398"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_119_w2aab3b7c17b1b6b1ab2b1d119Aa","doi-asserted-by":"crossref","unstructured":"Koenig, A.M., Mechanic-Hamilton, D., Xie, S.X., Combs, M.F., Cappola, A.R., Xie, L., Detre, J.A., Wolk, D.A., and Arnold, S.E. (2017). Effects of the insulin sensitizer Metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis. Assoc. Disord. 31, 107\u2013113.","DOI":"10.1097\/WAD.0000000000000202"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_120_w2aab3b7c17b1b6b1ab2b1d120Aa","doi-asserted-by":"crossref","unstructured":"Krauss, S., Griesche, N., Jastrzebska, E., Chen, C., Rutschow, D., Achm\u00fcller, C., Dorn, S., Boesch, S.M., Lalowski, M., Wanker, E., et al. (2013). Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat. Commun. 4, 1511.","DOI":"10.1038\/ncomms2514"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_121_w2aab3b7c17b1b6b1ab2b1d121Aa","doi-asserted-by":"crossref","unstructured":"Kuan, Y.C., Huang, K.W., Lin, C.L., Hu, C.J., and Kao, C.H. (2017). Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Prog. Neuropsychopharmacol. Biol. Psychiatry. 79, 77\u201383.","DOI":"10.1016\/j.pnpbp.2017.06.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_122_w2aab3b7c17b1b6b1ab2b1d122Aa","doi-asserted-by":"crossref","unstructured":"Kuhla, A., Brichmann, E., R\u00fchlmann, C., Thiele, R., Meuth, L., and Vollmar, B. (2019). Metformin therapy aggravates neurodegenerative processes in ApoE\u2212\/\u2212 mice. J. Alzheimers Dis. 68, 1415\u20131427.","DOI":"10.3233\/JAD-181017"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_123_w2aab3b7c17b1b6b1ab2b1d123Aa","doi-asserted-by":"crossref","unstructured":"Labbadia, J. and Morimoto, R. (2013). Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem. Sci. 38, 378\u2013385.","DOI":"10.1016\/j.tibs.2013.05.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_124_w2aab3b7c17b1b6b1ab2b1d124Aa","doi-asserted-by":"crossref","unstructured":"Labuschagne, I., Cassidy, A.M., Scahill, R.I., Johnson, E.B., Rees, E., O\u2019Regan, A., Queller, S., Frost, C., Leavitt, B.R., D\u00fcrr, A., et al. (2016). Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington\u2019s disease. J. Int. Neuropsychol. Soc. 22, 595\u2013608.","DOI":"10.1017\/S1355617716000321"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_125_w2aab3b7c17b1b6b1ab2b1d125Aa","doi-asserted-by":"crossref","unstructured":"Landwehrmeyer, G.B., Fitzer-Attas, C.J., Giuliano, J.D., Gon\u00e7alves, N., Anderson, K.E., Cardoso, F., Ferreira, J.J., Mestre, T.A., Stout, J.C., and Sampaio, C. (2017). Data analytics from Enroll-HD, a global clinical research platform for Huntington\u2019s disease. Mov. Disord. Clin. Pract. 4, 212\u2013224.","DOI":"10.1002\/mdc3.12388"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_126_w2aab3b7c17b1b6b1ab2b1d126Aa","doi-asserted-by":"crossref","unstructured":"Lane, D.J.R., Ayton, S., and Bush, A.I. (2018). Iron and Alzheimer\u2019s disease: an update on emerging mechanisms. J. Alzheimers Dis. 64, S379\u2013S395.","DOI":"10.3233\/JAD-179944"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_127_w2aab3b7c17b1b6b1ab2b1d127Aa","doi-asserted-by":"crossref","unstructured":"Languren, G., Montiel, T., Ram\u00edrez-Lugo, L., Balderas, I., S\u00e1nchez-Ch\u00e1vez, G., Sotres-Bay\u00f3n, F., Berm\u00fadez-Rattoni, F., and Massieu, L. (2019). Recurrent moderate hypoglycemia exacerbates oxidative damage and neuronal death leading to cognitive dysfunction after the hypoglycemic coma. J. Cereb. Blood Flow Metab. 39, 808\u2013821.","DOI":"10.1177\/0271678X17733640"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_128_w2aab3b7c17b1b6b1ab2b1d128Aa","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Tecedor, L., Chen, Y.H., Monteys, A.M., Sowada, M.J., Thompson, L.M., and Davidson, B.L. (2015). Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes. Neuron 85, 303\u2013315.","DOI":"10.1016\/j.neuron.2014.12.019"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_129_w2aab3b7c17b1b6b1ab2b1d129Aa","doi-asserted-by":"crossref","unstructured":"Leech, T., Chattipakorn, N., and Chattipakorn, S.C. (2019). The beneficial roles of metformin on the brain with cerebral ischaemia\/reperfusion injury. Pharmacol. Res. 146, 104261.","DOI":"10.1016\/j.phrs.2019.104261"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_130_w2aab3b7c17b1b6b1ab2b1d130Aa","doi-asserted-by":"crossref","unstructured":"Li, J., Benashski, S.E., Venna, V.R., and McCullough, L.D. (2010). Effects of metformin in experimental stroke. Stroke 41, 2645\u20132652.","DOI":"10.1161\/STROKEAHA.110.589697"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_131_w2aab3b7c17b1b6b1ab2b1d131Aa","doi-asserted-by":"crossref","unstructured":"Li, J., Deng, J., Sheng, W., and Zuo, Z. (2012). Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol. Biochem. Behav. 101, 564\u2013574.","DOI":"10.1016\/j.pbb.2012.03.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_132_w2aab3b7c17b1b6b1ab2b1d132Aa","doi-asserted-by":"crossref","unstructured":"Lin, C.H., Tallaksen-Greene, S., Chien, W.M., Cearley, J.A., Jackson, W.S., Crouse, A.B., Ren, S., Li, X.J., Albin, R.L., and Detloff, P.J. (2001). Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum. Mol. Genet. 10, 137\u2013144.","DOI":"10.1093\/hmg\/10.2.137"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_133_w2aab3b7c17b1b6b1ab2b1d133Aa","doi-asserted-by":"crossref","unstructured":"Lin, Y., Wang, K., Ma, C., Wang, X., Gong, Z., Zhang, R., Zang, D., and Cheng, Y. (2018). Evaluation of metformin on cognitive improvement in patients with non-dementia vascular cognitive impairment and abnormal glucose metabolism. Front. Aging Neurosci. 10, 227.","DOI":"10.3389\/fnagi.2018.00227"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_134_w2aab3b7c17b1b6b1ab2b1d134Aa","doi-asserted-by":"crossref","unstructured":"Ling, Y.Z., Li, Z.Y., Ou-Yang, H.D., Ma, C., Wu, S.L., Wei, J.Y., Ding, H.H., Zhang, X.L., Liu, M., Liu, C.C., et al. (2017). The inhibition of spinal synaptic plasticity mediated by activation of AMP-activated protein kinase signaling alleviates the acute pain induced by oxaliplatin. Exp. Neurol. 288, 85\u201393.","DOI":"10.1016\/j.expneurol.2016.11.009"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_135_w2aab3b7c17b1b6b1ab2b1d135Aa","doi-asserted-by":"crossref","unstructured":"Lipton, J.O. and Sahin, M. (2014). The neurology of mTOR. Neuron 84, 275\u2013291.","DOI":"10.1016\/j.neuron.2014.09.034"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_136_w2aab3b7c17b1b6b1ab2b1d136Aa","doi-asserted-by":"crossref","unstructured":"Liu, Y., Tang, G., Li, Y., Wang, Y., Chen, X., Gu, X., Zhang, Z., Wang, Y., and Yang, G.Y. (2014a). Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. J. Neuroinflamm. 11, 177.","DOI":"10.1186\/s12974-014-0177-4"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_137_w2aab3b7c17b1b6b1ab2b1d137Aa","doi-asserted-by":"crossref","unstructured":"Liu, Y., Tang, G., Zhang, Z., Wang, Y., and Yang, G.Y. (2014b). Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neurosci Lett. 579, 46\u201351.","DOI":"10.1016\/j.neulet.2014.07.006"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_138_w2aab3b7c17b1b6b1ab2b1d138Aa","doi-asserted-by":"crossref","unstructured":"Lu, M., Su, C., Qiao, C., Bian, Y., Ding, J., and Hu, G. (2016). Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int. J. Neuropsychopharmacol. 19.","DOI":"10.1093\/ijnp\/pyw047"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_139_w2aab3b7c17b1b6b1ab2b1d139Aa","doi-asserted-by":"crossref","unstructured":"Luchsinger, J.A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D.P., and Bagiella, E. (2016). Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial. J. Alzheimers Dis. 51, 501\u2013514.","DOI":"10.3233\/JAD-150493"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_140_w2aab3b7c17b1b6b1ab2b1d140Aa","doi-asserted-by":"crossref","unstructured":"Ludman, T. and Melemedjian, O.K. (2019). Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor \u03b1 and the consequent development of chemotherapy-induced painful peripheral neuropathy. Mol. Pain 15, 1744806919850043.","DOI":"10.1177\/1744806919850043"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_141_w2aab3b7c17b1b6b1ab2b1d141Aa","doi-asserted-by":"crossref","unstructured":"Luo, C., Wang, X., Huang, H., Mao, X., Zhou, H., and Liu, Z. (2019). Effect of metformin on antipsychotic-induced metabolic dysfunction: the potential role of gut-brain axis. Front. Pharmacol. 10, 371.","DOI":"10.3389\/fphar.2019.00371"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_142_w2aab3b7c17b1b6b1ab2b1d142Aa","doi-asserted-by":"crossref","unstructured":"Ma, T.C., Buescher, J.L., Oatis, B., Funk, J.A., Nash, A.J., Carrier, R.L., and Hoyt, K.R. (2007). Metformin therapy in a transgenic mouse model of Huntington\u2019s disease. Neurosci. Lett. 411, 98\u2013103.","DOI":"10.1016\/j.neulet.2006.10.039"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_143_w2aab3b7c17b1b6b1ab2b1d143Aa","doi-asserted-by":"crossref","unstructured":"Ma, J., Yu, H., Liu, J., Chen, Y., Wang, Q., and Xiang, L. (2015). Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur. J. Pharmacol. 764, 599\u2013606.","DOI":"10.1016\/j.ejphar.2015.06.010"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_144_w2aab3b7c17b1b6b1ab2b1d144Aa","doi-asserted-by":"crossref","unstructured":"Ma, J., Liu, J., Yu, H., Chen, Y., Wang, Q., and Xiang, L. (2016). Beneficial effect of Metformin on nerve regeneration and functional recovery after sciatic nerve crush injury in diabetic rats. Neurochem. Res. 41, 1130\u20131137.","DOI":"10.1007\/s11064-015-1803-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_145_w2aab3b7c17b1b6b1ab2b1d145Aa","doi-asserted-by":"crossref","unstructured":"Magnuson, B., Ekim, B., and Fingar, D.C. (2012). Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem. J. 441, 1\u201321.","DOI":"10.1042\/BJ20110892"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_146_w2aab3b7c17b1b6b1ab2b1d146Aa","doi-asserted-by":"crossref","unstructured":"Mairet-Coello, G., Courchet, J., Pieraut, S., Courchet, V., Maximov, A., and Polleux, F. (2013). The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A\u03b2 oligomers through \u03c4 phosphorylation. Neuron 78, 94\u2013108.","DOI":"10.1016\/j.neuron.2013.02.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_147_w2aab3b7c17b1b6b1ab2b1d147Aa","doi-asserted-by":"crossref","unstructured":"Manzo, E., Lorenzini, I., Barrameda, D., O\u2019Conner, A.G., Barrows, J.M., Starr, A., Kovalik, T., Rabichow, B.E., Lehmkuhl, E.M., Shreiner, D.D., et al. (2019). Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 8, pii: e45114. doi: 10.7554\/eLife.45114.","DOI":"10.7554\/eLife.45114"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_148_w2aab3b7c17b1b6b1ab2b1d148Aa","doi-asserted-by":"crossref","unstructured":"Mao-Ying, Q.L., Kavelaars, A., Krukowski, K., Huo, X.J., Zhou, W., Price, T.J., Cleeland, C., and Heijnen, C.J. (2014). The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One 9, e100701.","DOI":"10.1371\/journal.pone.0100701"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_149_w2aab3b7c17b1b6b1ab2b1d149Aa","doi-asserted-by":"crossref","unstructured":"Marinangeli, C., Didier, S., and Vingtdeux, V. (2016). AMPK in neurodegenerative diseases: implications and therapeutic perspectives. Curr. Drug Targets. 17, 890\u2013907.","DOI":"10.2174\/1389450117666160201105645"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_150_w2aab3b7c17b1b6b1ab2b1d150Aa","doi-asserted-by":"crossref","unstructured":"Markowicz-Piasecka, M., Sikora, J., Szyd\u0142owska, A., Skupie\u0144, A., Mikiciuk-Olasik, E., and Huttunen, K.M. (2017). Metformin \u2013 a future therapy for neurodegenerative diseases. Pharm. Res. 34, 2614\u20132627.","DOI":"10.1007\/s11095-017-2199-y"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_151_w2aab3b7c17b1b6b1ab2b1d151Aa","doi-asserted-by":"crossref","unstructured":"Markowicz-Piasecka, M., Huttunen, K.M., and Sikora, J. (2018). Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit \u03b2-amyloid aggregation. J. Enzyme Inhib. Med. Chem. 33, 1309\u20131322.","DOI":"10.1080\/14756366.2018.1499627"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_152_w2aab3b7c17b1b6b1ab2b1d152Aa","doi-asserted-by":"crossref","unstructured":"Mart\u00ed, E. (2016). RNA toxicity induced by expanded CAG repeats in Huntington\u2019s disease. Brain Pathol. 26, 779\u2013786.","DOI":"10.1111\/bpa.12427"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_153_w2aab3b7c17b1b6b1ab2b1d153Aa","doi-asserted-by":"crossref","unstructured":"Masaldan, S., Belaidi, A.A., Ayton, S., and Bush, A.I. (2019). Cellular senescence and iron dyshomeostasis in Alzheimer\u2019s disease. Pharmaceuticals (Basel, Switzerland) 12. pii: E93. doi: 10.3390\/ph12020093.","DOI":"10.3390\/ph12020093"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_154_w2aab3b7c17b1b6b1ab2b1d154Aa","doi-asserted-by":"crossref","unstructured":"Matthes, F., Hettich, M.M., Schilling, J., Flores-Dominguez, D., Blank, N., Wiglenda, T., Buntru, A., Wolf, H., Weber, S., Vorberg, I., et al. (2018). Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis. Cell Death Discov. 4, 4.","DOI":"10.1038\/s41420-017-0003-8"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_155_w2aab3b7c17b1b6b1ab2b1d155Aa","doi-asserted-by":"crossref","unstructured":"McColgan, P. and Tabrizi, S.J. (2017). Huntington\u2019s disease: a clinical review. Eur. J. Neurol. 25, 24\u201334.","DOI":"10.1111\/ene.13413"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_156_w2aab3b7c17b1b6b1ab2b1d156Aa","doi-asserted-by":"crossref","unstructured":"McGarry, A., McDermott, M., Kieburtz, K., de Blieck, E.A., Beal, F., Marder, K., Ross, C., Shoulson, I., Gilbert, P., Mallonee, W.M., et al. (2017). A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88, 152\u2013159.","DOI":"10.1212\/WNL.0000000000003478"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_157_w2aab3b7c17b1b6b1ab2b1d157Aa","doi-asserted-by":"crossref","unstructured":"Mehrabi, S., Sanadgol, N., Barati, M., Shahbazi, A., Vahabzadeh, G., Barzroudi, M., Seifi, M., Gholipourmalekabadi, M., and Golab, F. (2018). Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy. Metab. Brain Dis. 33, 107\u2013114.","DOI":"10.1007\/s11011-017-0132-z"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_158_w2aab3b7c17b1b6b1ab2b1d158Aa","doi-asserted-by":"crossref","unstructured":"Melemedjian, O.K., Asiedu, M.N., Tillu, D.V., Sanoja, R., Yan, J., Lark, A., Khoutorsky, A., Johnson, J., Peebles, K.A., Lepow, T., et al. (2011). Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol. Pain 7, 70.","DOI":"10.1186\/1744-8069-7-70"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_159_w2aab3b7c17b1b6b1ab2b1d159Aa","doi-asserted-by":"crossref","unstructured":"Menalled, L.B., Kudwa, A.E., Miller, S., Fitzpatrick, J., Watson-Johnson, J., Keating, N., Ruiz, M., Mushlin, R., Alosio, W., McConnell, K., et al. (2012). Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS One 7, e49838.","DOI":"10.1371\/journal.pone.0049838"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_160_w2aab3b7c17b1b6b1ab2b1d160Aa","doi-asserted-by":"crossref","unstructured":"Mielke, J.G., Taghibiglou, C., and Wang, Y.T. (2006). Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience 143, 165\u2013173.","DOI":"10.1016\/j.neuroscience.2006.07.055"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_161_w2aab3b7c17b1b6b1ab2b1d161Aa","doi-asserted-by":"crossref","unstructured":"Mima, Y., Kuwashiro, T., Yasaka, M., Tsurusaki, Y., Nakamura, A., Wakugawa, Y., and Okada, Y. (2016). Impact of metformin on the severity and outcomes of acute ischemic stroke in patients with type 2 diabetes mellitus. J. Stroke Cerebrovasc. Dis. 25, 436\u2013446.","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.016"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_162_w2aab3b7c17b1b6b1ab2b1d162Aa","doi-asserted-by":"crossref","unstructured":"M\u00f6ller, T. (2010). Neuroinflammation in Huntington\u2019s disease. J. Neural Transm. 117, 1001\u20131008.","DOI":"10.1007\/s00702-010-0430-7"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_163_w2aab3b7c17b1b6b1ab2b1d163Aa","doi-asserted-by":"crossref","unstructured":"Montojo, M.T., Aganzo, M., and Gonz\u00e1lez, N. (2017). Huntington\u2019s disease and diabetes: chronological sequence of its association. J. Huntington\u2019s Dis. 6, 179\u2013188.","DOI":"10.3233\/JHD-170253"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_164_w2aab3b7c17b1b6b1ab2b1d164Aa","doi-asserted-by":"crossref","unstructured":"Moore, E.M., Mander, A.G., Ames, D., Kotowicz, M.A., Carne, R.P., Brodaty, H., Woodward, M., Boundy, K., Ellis, K.A., Bush, A.I., et al. (2013). Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36, 2981\u20132987.","DOI":"10.2337\/dc13-0229"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_165_w2aab3b7c17b1b6b1ab2b1d165Aa","doi-asserted-by":"crossref","unstructured":"Moran, C., Callisaya, M.L., Srikanth, V., and Arvanitakis, Z. (2019). Diabetes therapies for dementia. Curr. Neurol. Neurosci. Rep. 19, 58.","DOI":"10.1007\/s11910-019-0973-4"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_166_w2aab3b7c17b1b6b1ab2b1d166Aa","doi-asserted-by":"crossref","unstructured":"Morgunova, G.V. and Klebanov, A.A. (2019). Age-related AMP-activated protein kinase alterations: from cellular energetics to longevity. Cell. Biochem. Funct. 37, 169\u2013176.","DOI":"10.1002\/cbf.3384"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_167_w2aab3b7c17b1b6b1ab2b1d167Aa","doi-asserted-by":"crossref","unstructured":"Morley, J.F., Brignull, H.R., Weyers, J.J., and Morimoto, R.I. (2002). The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 99, 10417\u201310422.","DOI":"10.1073\/pnas.152161099"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_168_w2aab3b7c17b1b6b1ab2b1d168Aa","doi-asserted-by":"crossref","unstructured":"Morsi, M., Maher, A., Aboelmagd, O., Johar, D., and Bernstein, L. (2018). A shared comparison of diabetes mellitus and neurodegenerative disorders. J. Cell. Biochem. 119, 1249\u20131256.","DOI":"10.1002\/jcb.26261"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_169_w2aab3b7c17b1b6b1ab2b1d169Aa","doi-asserted-by":"crossref","unstructured":"Mostafa, D.K., Ismail, C.A., and Ghareeb, D.A. (2016). Differential metformin dose-dependent effects on cognition in rats: role of Akt. Psychopharmacology (Berl.) 233, 2513\u20132524.","DOI":"10.1007\/s00213-016-4301-2"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_170_w2aab3b7c17b1b6b1ab2b1d170Aa","doi-asserted-by":"crossref","unstructured":"Mujica-Mota, M.A., Salehi, P., Devic, S., and Daniel, S.J. (2014). Safety and otoprotection of metformin in radiation-induced sensorineural hearing loss in the guinea pig. Otolaryngol. Head Neck Surg. 150, 859\u2013865.","DOI":"10.1177\/0194599814521013"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_171_w2aab3b7c17b1b6b1ab2b1d171Aa","doi-asserted-by":"crossref","unstructured":"Muri, L., Le, N.D., Zemp, J., Grandgirard, D., and Leib, S.L. (2019). Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis. J. Neuroinflammation. 16, 156.","DOI":"10.1186\/s12974-019-1549-6"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_172_w2aab3b7c17b1b6b1ab2b1d172Aa","doi-asserted-by":"crossref","unstructured":"Najafi, M., Cheki, M., Rezapoor, S., Geraily, G., Motevaseli, E., Carnovale, C., Clementi, E., and Shirazi, A. (2018). Metformin: prevention of genomic instability and cancer: a review. Mutat. Res. Genet. Toxicol. Environ. Mutagen 827, 1\u20138.","DOI":"10.1016\/j.mrgentox.2018.01.007"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_173_w2aab3b7c17b1b6b1ab2b1d173Aa","doi-asserted-by":"crossref","unstructured":"Nandini, H.S., Paudel, Y.N., and Krishna, K.L. (2019). Envisioning the neuroprotective effect of metformin in experimental epilepsy: a portrait of molecular crosstalk. Life Sci. 233, 116686.","DOI":"10.1016\/j.lfs.2019.116686"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_174_w2aab3b7c17b1b6b1ab2b1d174Aa","doi-asserted-by":"crossref","unstructured":"Nasir, J., Floresco, S.B., O\u2019Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G., and Hayden, M.R. (1995). Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823.","DOI":"10.1016\/0092-8674(95)90542-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_175_w2aab3b7c17b1b6b1ab2b1d175Aa","doi-asserted-by":"crossref","unstructured":"Nath, N., Khan, M., Paintlia, M.K., Singh, I., Hoda, M.N., and Giri, S. (2009). Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 182, 8005\u20138014.","DOI":"10.4049\/jimmunol.0803563"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_176_w2aab3b7c17b1b6b1ab2b1d176Aa","doi-asserted-by":"crossref","unstructured":"Neueder, A. and Bates, G.P. (2018). RNA related pathology in Huntington\u2019s disease. Adv. Exp. Med. Biol. 1049, 85\u2013101.","DOI":"10.1007\/978-3-319-71779-1_4"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_177_w2aab3b7c17b1b6b1ab2b1d177Aa","doi-asserted-by":"crossref","unstructured":"Niccoli, T., Cabecinha, M., Tillmann, A., Kerr, F., Wong, C.T., Cardenes, D., Vincent, A.J., Bettedi, L., Li, L., Gr\u00f6nke, S., et al. (2016). Increased glucose transport into neurons rescues A\u03b2 toxicity in Drosophila. Curr. Biol. 26, 2291\u20132300.","DOI":"10.1016\/j.cub.2016.07.017"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_178_w2aab3b7c17b1b6b1ab2b1d178Aa","doi-asserted-by":"crossref","unstructured":"Nitschke, F., Ahonen, S.J., Nitschke, S., Mitra, S., and Minassian, B.A. (2018). Lafora disease \u2013 from pathogenesis to treatment strategies. Nat. Rev. Neurol. 14, 606\u2013617.","DOI":"10.1038\/s41582-018-0057-0"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_179_w2aab3b7c17b1b6b1ab2b1d179Aa","doi-asserted-by":"crossref","unstructured":"Ochaba, J., Fote, G., Kachemov, M., Thein, S., Yeung, S.Y., Lau, A.L., Hernandez, S., Lim, R.G., Casale, M., Neel, M.J., et al. (2019). IKK\u03b2 slows Huntington\u2019s disease progression in R6\/1 mice. Proc. Natl. Acad. Sci. U.S.A. 116, 10952\u201310961.","DOI":"10.1073\/pnas.1814246116"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_180_w2aab3b7c17b1b6b1ab2b1d180Aa","doi-asserted-by":"crossref","unstructured":"Ona, V.O., Li, M., Vonsattel, J.P., Andrews, L.J., Khan, S.Q., Chung, W.M., Frey, A.S., Menon, A.S., Li, X.J., Stieg, P.E., et al. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399, 263\u2013267.","DOI":"10.1038\/20446"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_181_w2aab3b7c17b1b6b1ab2b1d181Aa","doi-asserted-by":"crossref","unstructured":"Onken, B. and Driscoll, M. (2010). Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One 5, e8758.","DOI":"10.1371\/journal.pone.0008758"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_182_w2aab3b7c17b1b6b1ab2b1d182Aa","doi-asserted-by":"crossref","unstructured":"Ou, Z., Kong, X., Sun, X., He, X., Zhang, L., Gong, Z., Huang, J., Xu, B., Long, D., Li, J., et al. (2018). Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice. Brain Behav. Immun. 69, 351\u2013363.","DOI":"10.1016\/j.bbi.2017.12.009"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_183_w2aab3b7c17b1b6b1ab2b1d183Aa","doi-asserted-by":"crossref","unstructured":"Owen, M.R., Doran, E., and Halestrap, A.P. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348(Pt 3), 607\u2013614.","DOI":"10.1042\/bj3480607"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_184_w2aab3b7c17b1b6b1ab2b1d184Aa","doi-asserted-by":"crossref","unstructured":"Paintlia, A.S., Mohan, S., and Singh, I. (2013a). Combinatorial effect of metformin and lovastatin impedes T-cell autoimmunity and neurodegeneration in experimental autoimmune encephalomyelitis. J. Clin. Cell. Immunol. 4. doi: 10.4172\/2155-9899.1000149.","DOI":"10.4172\/2155-9899.1000149"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_185_w2aab3b7c17b1b6b1ab2b1d185Aa","doi-asserted-by":"crossref","unstructured":"Paintlia, A.S., Paintlia, M.K., Mohan, S., Singh, A.K., and Singh, I. (2013b). AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am. J. Pathol. 183, 526\u2013541.","DOI":"10.1016\/j.ajpath.2013.04.030"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_186_w2aab3b7c17b1b6b1ab2b1d186Aa","doi-asserted-by":"crossref","unstructured":"Park, J.M., Jung, C.H., Seo, M., Otto, N.M., Grunwald, D., Kim, K.H., Moriarity, B., Kim, Y.M., Starker, C., Nho, R.S., et al. (2016). The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy 12, 547\u2013564.","DOI":"10.1080\/15548627.2016.1140293"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_187_w2aab3b7c17b1b6b1ab2b1d187Aa","doi-asserted-by":"crossref","unstructured":"Patil, S.P., Jain, P.D., Ghumatkar, P.J., Tambe, R., and Sathaye, S. (2014). Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277, 747\u2013754.","DOI":"10.1016\/j.neuroscience.2014.07.046"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_188_w2aab3b7c17b1b6b1ab2b1d188Aa","doi-asserted-by":"crossref","unstructured":"Peixoto, C.A., Oliveira, W.H.D., Ara\u00fajo, S.M.D.R., and Nunes, A.K.S. (2017a). AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp. Neurol. 298, 31\u201341.","DOI":"10.1016\/j.expneurol.2017.08.013"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_189_w2aab3b7c17b1b6b1ab2b1d189Aa","doi-asserted-by":"crossref","unstructured":"Peixoto, L.G., Teixeira, R.R., Vilela, D.D., Barbosa, L.N., Caixeta, D.C., Deconte, S.R., de Assis de Ara\u00fajo, F., Sabino-Silva, R., and Espindola, F.S. (2017b). Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats. Acta Diabetol. 54, 943\u2013951.","DOI":"10.1007\/s00592-017-1027-5"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_190_w2aab3b7c17b1b6b1ab2b1d190Aa","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Revuelta, B.I., Hettich, M.M., Ciociaro, A., Rotermund, C., Kahle, P.J., Krauss, S., and Di Monte, D.A. (2014). Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis. 5, e1209.","DOI":"10.1038\/cddis.2014.175"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_191_w2aab3b7c17b1b6b1ab2b1d191Aa","doi-asserted-by":"crossref","unstructured":"Pernicova, I. and Korbonits, M. (2014). Metformin-mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10, 143\u2013156.","DOI":"10.1038\/nrendo.2013.256"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_192_w2aab3b7c17b1b6b1ab2b1d192Aa","doi-asserted-by":"crossref","unstructured":"Picone, P., Nuzzo, D., Caruana, L., Messina, E., Barera, A., Vasto, S., and Di Carlo, M. (2015). Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-\u03baB activation: use of insulin to attenuate metformin\u2019s effect. Biochim. Biophys. Acta 1853, 1046\u20131059.","DOI":"10.1016\/j.bbamcr.2015.01.017"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_193_w2aab3b7c17b1b6b1ab2b1d193Aa","doi-asserted-by":"crossref","unstructured":"Picone, P., Vilasi, S., Librizzi, F., Contardi, M., Nuzzo, D., Caruana, L., Baldassano, S., Amato, A., Mul\u00e8, F., San Biagio, P.L., et al.  (2016). Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates. Aging 8, 1718\u20131734.","DOI":"10.18632\/aging.101004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_194_w2aab3b7c17b1b6b1ab2b1d194Aa","doi-asserted-by":"crossref","unstructured":"Pinto, R.M., Dragileva, E., Kirby, A., Lloret, A., Lopez, E., St Claire, J., Panigrahi, G.B., Hou, C., Holloway, K., Gillis, T., et al. (2013). Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet. 9, e1003930.","DOI":"10.1371\/journal.pgen.1003930"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_195_w2aab3b7c17b1b6b1ab2b1d195Aa","doi-asserted-by":"crossref","unstructured":"Poirier, M.A., Jiang, H., and Ross, C.A. (2005). A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact \u03b2-sheet structure. Hum. Mol. Genet. 14, 765\u2013774.","DOI":"10.1093\/hmg\/ddi071"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_196_w2aab3b7c17b1b6b1ab2b1d196Aa","doi-asserted-by":"crossref","unstructured":"Porceddu, P.F., Ishola, I.O., Contu, L., and Morelli, M. (2016). Metformin prevented dopaminergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine administration. Neurotoxicol. Res. 30, 101\u2013109.","DOI":"10.1007\/s12640-016-9633-5"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_197_w2aab3b7c17b1b6b1ab2b1d197Aa","doi-asserted-by":"crossref","unstructured":"Porter, K.M., Ward, M., Hughes, C.F., O\u2019Kane, M., Hoey, L., McCann, A., Molloy, A.M., Cunningham, C., Casey, M., Tracey, F., et al. (2019). Hyperglycemia and metformin use are associated with B-vitamin deficiency and cognitive dysfunction in older adults. J. Clin. Endocrinol. Metab. 104, 4837\u20134847.","DOI":"10.1210\/jc.2018-01791"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_198_w2aab3b7c17b1b6b1ab2b1d198Aa","doi-asserted-by":"crossref","unstructured":"Protic, D., Aydin, E.Y., Tassone, F., Tan, M.M., Hagerman, R.J., and Schneider, A. (2019). Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin \u2013 two cases. Mol. Genet. Genom. Med. 7, e00745.","DOI":"10.1002\/mgg3.745"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_199_w2aab3b7c17b1b6b1ab2b1d199Aa","doi-asserted-by":"crossref","unstructured":"Rabanal-Ruiz, Y., Otten, E.G., and Korolchuk, V.I. (2017). mTORC1 as the main gateway to autophagy. Essays Biochem. 61, 565\u2013584.","DOI":"10.1042\/EBC20170027"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_200_w2aab3b7c17b1b6b1ab2b1d200Aa","doi-asserted-by":"crossref","unstructured":"Ratovitski, T., Gucek, M., Jiang, H., Chighladze, E., Waldron, E., D\u2019Ambola, J., Hou, Z., Liang, Y., Poirier, M.A., Hirschhorn, R.R., et al. (2009). Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J. Biol. Chem. 284, 10855\u201310867.","DOI":"10.1074\/jbc.M804813200"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_201_w2aab3b7c17b1b6b1ab2b1d201Aa","doi-asserted-by":"crossref","unstructured":"Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O\u2019Kane, C.J., et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595.","DOI":"10.1038\/ng1362"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_202_w2aab3b7c17b1b6b1ab2b1d202Aa","doi-asserted-by":"crossref","unstructured":"Rawlins, M.D., Wexler, N.S., Wexler, A.R., Tabrizi, S.J., Douglas, I., Evans, S.J.W., and Smeeth, L. (2016). The prevalence of Huntington\u2019s disease. Neuroepidemiology 46, 144\u2013153.","DOI":"10.1159\/000443738"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_203_w2aab3b7c17b1b6b1ab2b1d203Aa","doi-asserted-by":"crossref","unstructured":"Rojas, L.B.A. and Gomes, M.B. (2013). Metformin: an old but still the best treatment for type 2 diabetes. Diabetol. Metab. Syndr. 5, 6.","DOI":"10.1186\/1758-5996-5-6"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_204_w2aab3b7c17b1b6b1ab2b1d204Aa","doi-asserted-by":"crossref","unstructured":"Roscic, A., Baldo, B., Crochemore, C., Marcellin, D., and Paganetti, P. (2011). Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. J. Neurochem. 119, 398\u2013407.","DOI":"10.1111\/j.1471-4159.2011.07435.x"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_205_w2aab3b7c17b1b6b1ab2b1d205Aa","doi-asserted-by":"crossref","unstructured":"Rotermund, C., Machetanz, G., and Fitzgerald, J.C. (2018). The therapeutic potential of metformin in neurodegenerative diseases. Front. Endocrinol. 9, 400.","DOI":"10.3389\/fendo.2018.00400"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_206_w2aab3b7c17b1b6b1ab2b1d206Aa","doi-asserted-by":"crossref","unstructured":"Rubio Osornio, M.D.C., Custodio Ram\u00edrez, V., Calder\u00f3n G\u00e1mez, D., Paz Tres, C., Carvajal Aguilera, K.G., and Phillips Farf\u00e1n, B.V. (2018). Metformin plus caloric restriction show anti-epileptic effects mediated by mTOR pathway inhibition. Cell Mol. Neurobiol. 38, 1425\u20131438.","DOI":"10.1007\/s10571-018-0611-8"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_207_w2aab3b7c17b1b6b1ab2b1d207Aa","doi-asserted-by":"crossref","unstructured":"Ruderman, N.B., Xu, X.J., Nelson, L., Cacicedo, J.M., Saha, A.K., Lan, F., and Ido, Y. (2010). AMPK and SIRT1: a long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 298, E751\u2013E760.","DOI":"10.1152\/ajpendo.00745.2009"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_208_w2aab3b7c17b1b6b1ab2b1d208Aa","doi-asserted-by":"crossref","unstructured":"Ru\u00e9, L., Ba\u00f1ez-Coronel, M., Creus-Muncunill, J., Giralt, A., Alcal\u00e1-Vida, R., Mentxaka, G., Kagerbauer, B., Zome\u00f1o-Abell\u00e1n, M.T., Aranda, Z., Venturi, V., et al. (2016). Targeting CAG repeat RNAs reduces Huntington\u2019s disease phenotype independently of huntingtin levels. J. Clin. Invest. 126, 4319\u20134330.","DOI":"10.1172\/JCI83185"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_209_w2aab3b7c17b1b6b1ab2b1d209Aa","doi-asserted-by":"crossref","unstructured":"Rui, Y.N., Xu, Z., Patel, B., Chen, Z., Chen, D., Tito, A., David, G., Sun, Y., Stimming, E.F., Bellen, H.J., et al. (2015). Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell. Biol. 17, 262\u2013275.","DOI":"10.1038\/ncb3101"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_210_w2aab3b7c17b1b6b1ab2b1d210Aa","doi-asserted-by":"crossref","unstructured":"Russe, O.Q., M\u00f6ser, C.V., Kynast, K.L., King, T.S., Stephan, H., Geisslinger, G., and Niederberger, E. (2013). Activation of the AMP-activated protein kinase reduces inflammatory nociception. J. Pain 14, 1330\u20131340.","DOI":"10.1016\/j.jpain.2013.05.012"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_211_w2aab3b7c17b1b6b1ab2b1d211Aa","doi-asserted-by":"crossref","unstructured":"Ryu, Y.K., Park, H.Y., Go, J., Choi, D.H., Kim, Y.H., Hwang, J.H., Noh, J.R., Lee, T.G., Lee, C.H., and Kim, K.S. (2018). Metformin inhibits the development of L-DOPA-induced dyskinesia in a murine model of Parkinson\u2019s disease. Mol. Neurobiol. 55, 5715\u20135726.","DOI":"10.1007\/s12035-017-0752-7"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_212_w2aab3b7c17b1b6b1ab2b1d212Aa","doi-asserted-by":"crossref","unstructured":"Salminen, A., Hyttinen, J.M.T., and Kaarniranta, K. (2011). AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. 89, 667\u2013676.","DOI":"10.1007\/s00109-011-0748-0"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_213_w2aab3b7c17b1b6b1ab2b1d213Aa","doi-asserted-by":"crossref","unstructured":"Salminen, A., Kaarniranta, K., and Kauppinen, A. (2016). Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Res. Rev. 28, 15\u201326.","DOI":"10.1016\/j.arr.2016.04.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_214_w2aab3b7c17b1b6b1ab2b1d214Aa","doi-asserted-by":"crossref","unstructured":"Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., and Sabatini, D.M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501.","DOI":"10.1126\/science.1157535"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_215_w2aab3b7c17b1b6b1ab2b1d215Aa","doi-asserted-by":"crossref","unstructured":"Sanchis, A., Garc\u00eda-Gimeno, M.A., Ca\u00f1ada-Mart\u00ednez, A.J., Sequedo, M.D., Mill\u00e1n, J.M., Sanz, P., and V\u00e1zquez-Manrique, R.P. (2019). Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease. Exp. Mol. Med. 51, 65.","DOI":"10.1038\/s12276-019-0264-9"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_216_w2aab3b7c17b1b6b1ab2b1d216Aa","doi-asserted-by":"crossref","unstructured":"Santo, E.E. and Paik, J. (2018). FOXO in neural cells and diseases of the nervous system. Curr. Top. Dev. Biol. 127, 105\u2013118.","DOI":"10.1016\/bs.ctdb.2017.10.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_217_w2aab3b7c17b1b6b1ab2b1d217Aa","doi-asserted-by":"crossref","unstructured":"Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D.M. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302.","DOI":"10.1016\/j.cub.2004.06.054"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_218_w2aab3b7c17b1b6b1ab2b1d218Aa","doi-asserted-by":"crossref","unstructured":"Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. (2005). Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307, 1098\u20131101.","DOI":"10.1126\/science.1106148"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_219_w2aab3b7c17b1b6b1ab2b1d219Aa","doi-asserted-by":"crossref","unstructured":"Sarkar, S., Ravikumar, B., Floto, R.A., and Rubinsztein, D.C. (2009). Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16, 46\u201356.","DOI":"10.1038\/cdd.2008.110"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_220_w2aab3b7c17b1b6b1ab2b1d220Aa","doi-asserted-by":"crossref","unstructured":"Sathasivam, K., Neueder, A., Gipson, T.A., Landles, C., Benjamin, A.C., Bondulich, M.K., Smith, D.L., Faull, R.L.M., Roos, R.A.C., Howland, D., et al. (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 110, 2366\u20132370.","DOI":"10.1073\/pnas.1221891110"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_221_w2aab3b7c17b1b6b1ab2b1d221Aa","doi-asserted-by":"crossref","unstructured":"Saudou, F. and Humbert, S. (2016). The biology of Huntingtin. Neuron 89, 910\u2013926.","DOI":"10.1016\/j.neuron.2016.02.003"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_222_w2aab3b7c17b1b6b1ab2b1d222Aa","doi-asserted-by":"crossref","unstructured":"Saudubray, J.M. and Garcia-Cazorla, A. (2018). An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders. Dialogues Clin. Neurosci. 20, 301\u2013325.","DOI":"10.31887\/DCNS.2018.20.4\/jmsaudubray"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_223_w2aab3b7c17b1b6b1ab2b1d223Aa","doi-asserted-by":"crossref","unstructured":"Saxton, R.A. and Sabatini, D.M. (2017). mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976.","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_224_w2aab3b7c17b1b6b1ab2b1d224Aa","doi-asserted-by":"crossref","unstructured":"Son, S.M., Shin, H.J., Byun, J., Kook, S.Y., Moon, M., Chang, Y.J., and Mook-Jung, I. (2016). Metformin facilitates amyloid-\u03b2 generation by \u03b2- and \u03b3-secretases via autophagy activation. J. Alzheimers Dis. 51, 1197\u20131208.","DOI":"10.3233\/JAD-151200"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_225_w2aab3b7c17b1b6b1ab2b1d225Aa","doi-asserted-by":"crossref","unstructured":"Strand, A.D., Baquet, Z.C., Aragaki, A.K., Holmans, P., Yang, L., Cleren, C., Beal, M.F., Jones, L., Kooperberg, C., Olson, J.M., et al. (2007). Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J. Neurosci. 27, 11758\u201311768.","DOI":"10.1523\/JNEUROSCI.2461-07.2007"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_226_w2aab3b7c17b1b6b1ab2b1d226Aa","doi-asserted-by":"crossref","unstructured":"Subramaniam, S., Sixt, K.M., Barrow, R., and Snyder, S.H. (2009). Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327\u20131330.","DOI":"10.1126\/science.1172871"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_227_w2aab3b7c17b1b6b1ab2b1d227Aa","doi-asserted-by":"crossref","unstructured":"Sun, Y., Tian, T., Gao, J., Liu, X., Hou, H., Cao, R., Li, B., Quan, M., and Guo, L. (2016). Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice. J. Neuroimmunol. 292, 58\u201367.","DOI":"10.1016\/j.jneuroim.2016.01.014"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_228_w2aab3b7c17b1b6b1ab2b1d228Aa","doi-asserted-by":"crossref","unstructured":"Swarnkar, S., Chen, Y., Pryor, W.M., Shahani, N., Page, D.T., and Subramaniam, S. (2015). Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington\u2019s disease. Neurobiol. Dis. 82, 66\u201377.","DOI":"10.1016\/j.nbd.2015.05.011"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_229_w2aab3b7c17b1b6b1ab2b1d229Aa","doi-asserted-by":"crossref","unstructured":"Tabrizi, S.J., Leavitt, B.R., Landwehrmeyer, G.B., Wild, E.J., Saft, C., Barker, R.A., Blair, N.F., Craufurd, D., Priller, J., Rickards, H., et al. (2019). Targeting Huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316.","DOI":"10.1056\/NEJMoa1900907"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_230_w2aab3b7c17b1b6b1ab2b1d230Aa","doi-asserted-by":"crossref","unstructured":"Taheri, A., Emami, M., Asadipour, E., Kasirzadeh, S., Rouini, M.R., Najafi, A., Heshmat, R., Abdollahi, M., and Mojtahedzadeh, M. (2019). A randomized controlled trial on the efficacy, safety, and pharmacokinetics of metformin in severe traumatic brain injury. J. Neurol. 266, 1988\u20131997.","DOI":"10.1007\/s00415-019-09366-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_231_w2aab3b7c17b1b6b1ab2b1d231Aa","doi-asserted-by":"crossref","unstructured":"Tanokashira, D., Kurata, E., Fukuokaya, W., Kawabe, K., Kashiwada, M., Takeuchi, H., Nakazato, M., and Taguchi, A. (2018). Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1. FEBS Open Bio 8, 1104\u20131118.","DOI":"10.1002\/2211-5463.12436"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_232_w2aab3b7c17b1b6b1ab2b1d232Aa","doi-asserted-by":"crossref","unstructured":"Tao, L., Li, D., Liu, H., Jiang, F., Xu, Y., Cao, Y., Gao, R., and Chen, G. (2018). Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-\u03baB and MAPK signaling pathway. Brain Res. Bull. 140, 154\u2013161.","DOI":"10.1016\/j.brainresbull.2018.04.008"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_233_w2aab3b7c17b1b6b1ab2b1d233Aa","doi-asserted-by":"crossref","unstructured":"Tayara, K., Espinosa-Oliva, A.M., Garc\u00eda-Dom\u00ednguez, I., Ismaiel, A.A., Boza-Serrano, A., Deierborg, T., Machado, A., Herrera, A.J., Venero, J.L., and de Pablos, R.M. (2018). Divergent effects of metformin on an inflammatory model of Parkinson\u2019s disease. Front. Cell. Neurosci. 12, 440.","DOI":"10.3389\/fncel.2018.00440"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_234_w2aab3b7c17b1b6b1ab2b1d234Aa","doi-asserted-by":"crossref","unstructured":"Templeman, N.M. and Murphy, C.T. (2018). Regulation of reproduction and longevity by nutrient-sensing pathways. J. Cell. Biol. 217, 93\u2013106.","DOI":"10.1083\/jcb.201707168"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_235_w2aab3b7c17b1b6b1ab2b1d235Aa","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_236_w2aab3b7c17b1b6b1ab2b1d236Aa","doi-asserted-by":"crossref","unstructured":"Thompson, L.M., Aiken, C.T., Kaltenbach, L.S., Agrawal, N., Illes, K., Khoshnan, A., Martinez-Vincente, M., Arrasate, M., O\u2019Rourke, J.G., Khashwji, H., et al. (2009). IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell. Biol. 187, 1083\u20131099.","DOI":"10.1083\/jcb.200909067"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_237_w2aab3b7c17b1b6b1ab2b1d237Aa","doi-asserted-by":"crossref","unstructured":"Timmons, J.A., Volmar, C.H., Crossland, H., Phillips, B.E., Sood, S., Janczura, K.J., T\u00f6rm\u00e4kangas, T., Kujala, U.M., Kraus, W.E., Atherton, P.J., et al. (2019). Longevity-related molecular pathways are subject to midlife \u2018switch\u2019 in humans. Aging Cell 18, e12970.","DOI":"10.1111\/acel.12970"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_238_w2aab3b7c17b1b6b1ab2b1d238Aa","doi-asserted-by":"crossref","unstructured":"Tomasoni, R. and Mondino, A. (2011). The tuberous sclerosis complex: balancing proliferation and survival. Biochem. Soc. Trans. 39, 466\u2013471.","DOI":"10.1042\/BST0390466"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_239_w2aab3b7c17b1b6b1ab2b1d239Aa","doi-asserted-by":"crossref","unstructured":"Trettel, F., Rigamonti, D., Hilditch-Maguire, P., Wheeler, V.C., Sharp, A.H., Persichetti, F., Cattaneo, E., and MacDonald, M.E. (2000). Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799\u20132809.","DOI":"10.1093\/hmg\/9.19.2799"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_240_w2aab3b7c17b1b6b1ab2b1d240Aa","doi-asserted-by":"crossref","unstructured":"Ullah, I., Ullah, N., Naseer, M.I., Lee, H.Y., and Kim, M.O.K. (2012). Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neurosci. 13, 11.","DOI":"10.1186\/1471-2202-13-11"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_241_w2aab3b7c17b1b6b1ab2b1d241Aa","doi-asserted-by":"crossref","unstructured":"Vancura, A., Bu, P., Bhagwat, M., Zeng, J., and Vancurova, I. (2018). Metformin as an anticancer agent. Trends Pharmacol. Sci. 39, 867\u2013878.","DOI":"10.1016\/j.tips.2018.07.006"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_242_w2aab3b7c17b1b6b1ab2b1d242Aa","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Manrique, R.P., Farina, F., Cambon, K., Dolores Sequedo, M., Parker, A.J., Mill\u00e1n, J.M., Weiss, A., D\u00e9glon, N., and Neri, C. (2016). AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington\u2019s disease. Hum. Mol. Genet. 25, 1043\u20131058.","DOI":"10.1093\/hmg\/ddv513"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_243_w2aab3b7c17b1b6b1ab2b1d243Aa","doi-asserted-by":"crossref","unstructured":"Veldman, M.B. and Yang, X.W. (2018). Molecular insights into cortico-striatal miscommunications in Huntington\u2019s disease. Curr. Opin. Neurobiol. 48, 79\u201389.","DOI":"10.1016\/j.conb.2017.10.019"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_244_w2aab3b7c17b1b6b1ab2b1d244Aa","doi-asserted-by":"crossref","unstructured":"Viollet, B., Guigas, B., Sanz Garcia, N., Leclerc, J., Foretz, M., and Andreelli, F. (2012). Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. (Lond.) 122, 253\u2013270.","DOI":"10.1042\/CS20110386"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_245_w2aab3b7c17b1b6b1ab2b1d245Aa","doi-asserted-by":"crossref","unstructured":"Vuong, K., Canning, C.G., Menant, J.C., and Loy, C.T. (2018). Gait, balance, and falls in Huntington disease. Handb. Clin. Neurol. 159, 251\u2013260.","DOI":"10.1016\/B978-0-444-63916-5.00016-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_246_w2aab3b7c17b1b6b1ab2b1d246Aa","doi-asserted-by":"crossref","unstructured":"Wahlqvist, M.L., Lee, M.S., Hsu, C.C., Chuang, S.Y., Lee, J.T., and Tsai, H.N. (2012). Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat. Disord. 18, 753\u2013758.","DOI":"10.1016\/j.parkreldis.2012.03.010"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_247_w2aab3b7c17b1b6b1ab2b1d247Aa","doi-asserted-by":"crossref","unstructured":"Wang, T., Yu, Q., Chen, J., Deng, B., Qian, L., and Le, Y. (2010). PP2A mediated AMPK inhibition promotes HSP70 expression in heat shock response. PLoS One 5, pii: e13096. doi: 10.1371\/journal.pone.0013096.","DOI":"10.1371\/journal.pone.0013096"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_248_w2aab3b7c17b1b6b1ab2b1d248Aa","doi-asserted-by":"crossref","unstructured":"Wang, J., Gallagher, D., DeVito, L.M., Cancino, G.I., Tsui, D., He, L., Keller, G.M., Frankland, P.W., Kaplan, D.R., and Miller, F.D. (2012). Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell. Stem Cell 11, 23\u201335.","DOI":"10.1016\/j.stem.2012.03.016"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_249_w2aab3b7c17b1b6b1ab2b1d249Aa","doi-asserted-by":"crossref","unstructured":"Wang, C., Liu, C., Gao, K., Zhao, H., Zhou, Z., Shen, Z., Guo, Y., Li, Z., Yao, T., and Mei, X. (2016). Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury. Biochem. Biophys. Res. Commun. 477, 534\u2013540.","DOI":"10.1016\/j.bbrc.2016.05.148"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_250_w2aab3b7c17b1b6b1ab2b1d250Aa","doi-asserted-by":"crossref","unstructured":"Wang, L., Cai, Y., and Fan, X. (2018). Metformin administration during early postnatal life rescues autistic-like behaviors in the BTBR T+ Itpr3tf\/J mouse model of autism. Front. Behav. Neurosci. 12, 290.","DOI":"10.3389\/fnbeh.2018.00290"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_251_w2aab3b7c17b1b6b1ab2b1d251Aa","doi-asserted-by":"crossref","unstructured":"Wang, X., Luo, C., Mao, X.Y., Li, X., Yin, J.Y., Zhang, W., Zhou, H.H., and Liu, Z.Q. (2019). Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats. Brain Res. 1719, 30\u201339.","DOI":"10.1016\/j.brainres.2019.05.023"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_252_w2aab3b7c17b1b6b1ab2b1d252Aa","doi-asserted-by":"crossref","unstructured":"Williams, T., Courchet, J., Viollet, B., Brenman, J.E., and Polleux, F. (2011). AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress. Proc. Natl. Acad. Sci. U.S.A. 108, 5849\u20135854.","DOI":"10.1073\/pnas.1013660108"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_253_w2aab3b7c17b1b6b1ab2b1d253Aa","doi-asserted-by":"crossref","unstructured":"Wlodarchak, N. and Xing, Y. (2016). PP2A as a master regulator of the cell cycle. Crit. Rev. Biochem. Mol. Biol. 51, 162\u2013184.","DOI":"10.3109\/10409238.2016.1143913"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_254_w2aab3b7c17b1b6b1ab2b1d254Aa","doi-asserted-by":"crossref","unstructured":"Wold, M.S., Lim, J., Lachance, V., Deng, Z., and Yue, Z. (2016). ULK1-mediated phosphorylation of ATG14 promotes autophagy and is impaired in Huntington\u2019s disease models. Mol. Neurodegener. 11, 76.","DOI":"10.1186\/s13024-016-0141-0"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_255_w2aab3b7c17b1b6b1ab2b1d255Aa","doi-asserted-by":"crossref","unstructured":"Wu, Y., Song, P., Xu, J., Zhang, M., and Zou, M.H. (2007). Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282, 9777\u20139788.","DOI":"10.1074\/jbc.M608310200"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_256_w2aab3b7c17b1b6b1ab2b1d256Aa","doi-asserted-by":"crossref","unstructured":"Wyttenbach, A., Hands, S., King, M.A., Lipkow, K., and Tolkovsky, A.M. (2008). Amelioration of protein misfolding disease by rapamycin: translation or autophagy? Autophagy 4, 542\u2013545.","DOI":"10.4161\/auto.6059"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_257_w2aab3b7c17b1b6b1ab2b1d257Aa","doi-asserted-by":"crossref","unstructured":"Xu, Y., Liu, C., Chen, S., Ye, Y., Guo, M., Ren, Q., Liu, L., Zhang, H., Xu, C., Zhou, Q., et al. (2014). Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease. Cell. Signal. 26, 1680\u20131689.","DOI":"10.1016\/j.cellsig.2014.04.009"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_258_w2aab3b7c17b1b6b1ab2b1d258Aa","doi-asserted-by":"crossref","unstructured":"Yan, L., Mieulet, V., Burgess, D., Findlay, G.M., Sully, K., Procter, J., Goris, J., Janssens, V., Morrice, N.A., and Lamb, R.F. (2010). PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Mol. Cell. 37, 633\u2013642.","DOI":"10.1016\/j.molcel.2010.01.031"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_259_w2aab3b7c17b1b6b1ab2b1d259Aa","doi-asserted-by":"crossref","unstructured":"Yan, Q., Han, C., Wang, G., Waddington, J.L., Zheng, L., and Zhen, X. (2017). Activation of AMPK\/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death. Mol. Pharmacol. 92, 640\u2013652.","DOI":"10.1124\/mol.117.109512"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_260_w2aab3b7c17b1b6b1ab2b1d260Aa","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhu, B., Zheng, F., Li, Y., Zhang, Y., Hu, Y., and Wang, X. (2017). Chronic metformin treatment facilitates seizure termination. Biochem. Biophys. Res. Commun. 484, 450\u2013455.","DOI":"10.1016\/j.bbrc.2017.01.157"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_261_w2aab3b7c17b1b6b1ab2b1d261Aa","doi-asserted-by":"crossref","unstructured":"Yimer, E.M., Surur, A., Wondafrash, D.Z., and Gebre, A.K. (2019). The effect of metformin in experimentally induced animal models of epileptic seizure. Behav. Neurol. 2019, 6234758.","DOI":"10.1155\/2019\/6234758"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_262_w2aab3b7c17b1b6b1ab2b1d262Aa","doi-asserted-by":"crossref","unstructured":"Yuan, R., Wang, Y., Li, Q., Zhen, F., Li, X., Lai, Q., Hu, P., Wang, X., Zhu, Y., Fan, H., et al. (2019). Metformin reduces neuronal damage and promotes neuroblast proliferation and differentiation in a cerebral ischemia\/reperfusion rat model. Neuroreport 30, 232\u2013240.","DOI":"10.1097\/WNR.0000000000001190"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_263_w2aab3b7c17b1b6b1ab2b1d263Aa","doi-asserted-by":"crossref","unstructured":"Zeitler, B., Froelich, S., Marlen, K., Shivak, D.A., Yu, Q., Li, D., Pearl, J.R., Miller, J.C., Zhang, L., Paschon, D.E., et al. (2019). Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease. Nat. Med. 25, 1131\u20131142.","DOI":"10.1038\/s41591-019-0478-3"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_264_w2aab3b7c17b1b6b1ab2b1d264Aa","doi-asserted-by":"crossref","unstructured":"Zeitlin, S., Liu, J.P., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat. Genet. 11, 155\u2013163.","DOI":"10.1038\/ng1095-155"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_265_w2aab3b7c17b1b6b1ab2b1d265Aa","doi-asserted-by":"crossref","unstructured":"Zhang, D., Xuan, J., Zheng, B.B., Zhou, Y.L., Lin, Y., Wu, Y.S., Zhou, Y.F., Huang, Y.X., Wang, Q., Shen, L.Y., et al. (2017a). Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation. Mol. Neurobiol. 54, 3327\u20133341.","DOI":"10.1007\/s12035-016-9895-1"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_266_w2aab3b7c17b1b6b1ab2b1d266Aa","doi-asserted-by":"crossref","unstructured":"Zhang, J., Cai, Q., Jiang, M., Liu, Y., Gu, H., Guo, J., Sun, H., Fang, J., and Jin, L. (2017b). Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK\/mTOR mediated autophagic inhibition. Exp. Gerontol. 89, 45\u201356.","DOI":"10.1016\/j.exger.2017.01.010"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_267_w2aab3b7c17b1b6b1ab2b1d267Aa","doi-asserted-by":"crossref","unstructured":"Zhang, J., Culp, M.L., Craver, J.G., and Darley-Usmar, V. (2018). Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson\u2019s disease. J. Neurochem. 144, 691\u2013709.","DOI":"10.1111\/jnc.14308"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_268_w2aab3b7c17b1b6b1ab2b1d268Aa","doi-asserted-by":"crossref","unstructured":"Zhang, J., Lin, Y., Dai, X., Fang, W., Wu, X., and Chen, X. (2019). Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner. FASEB J. 33, 7748\u20137757.","DOI":"10.1096\/fj.201802718R"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_269_w2aab3b7c17b1b6b1ab2b1d269Aa","doi-asserted-by":"crossref","unstructured":"Zhao, M., Li, X.W., Chen, D.Z., Hao, F., Tao, S.X., Yu, H.Y., Cheng, R., and Liu, H. (2019a). Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK\/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Med. Sci. Monit. 25, 2186\u20132194.","DOI":"10.12659\/MSM.911250"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_270_w2aab3b7c17b1b6b1ab2b1d270Aa","doi-asserted-by":"crossref","unstructured":"Zhao, X., Zeng, Z., Gaur, U., Fang, J., Peng, T., Li, S., and Zheng, W. (2019b). Metformin protects PC12 cells and hippocampal neurons from H2O2-induced oxidative damage through activation of AMPK pathway. J. Cell. Physiol. (in press). Available at: https:\/\/doi.org\/10.1002\/jcp.28337.","DOI":"10.1002\/jcp.28337"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_271_w2aab3b7c17b1b6b1ab2b1d271Aa","doi-asserted-by":"crossref","unstructured":"Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167\u20131174.","DOI":"10.1172\/JCI13505"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_272_w2aab3b7c17b1b6b1ab2b1d272Aa","doi-asserted-by":"crossref","unstructured":"Zhou, C., Sun, R., Zhuang, S., Sun, C., Jiang, Y., Cui, Y., Li, S., Xiao, Y., Du, Y., Gu, H., et al. (2016a). Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity. Brain Res. Bull. 121, 241\u2013245.","DOI":"10.1016\/j.brainresbull.2016.02.009"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_273_w2aab3b7c17b1b6b1ab2b1d273Aa","doi-asserted-by":"crossref","unstructured":"Zhou, W., Kavelaars, A., and Heijnen, C.J. (2016b). Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One 11, e0151890.","DOI":"10.1371\/journal.pone.0151890"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_274_w2aab3b7c17b1b6b1ab2b1d274Aa","doi-asserted-by":"crossref","unstructured":"Zhou, J., Massey, S., Story, D., and Li, L. (2018). Metformin: an old drug with new applications. Int. J. Mol. Sci. 19, pii: E2863. doi: 10.3390\/ijms19102863.","DOI":"10.3390\/ijms19102863"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_275_w2aab3b7c17b1b6b1ab2b1d275Aa","doi-asserted-by":"crossref","unstructured":"Zhou, B., Liu, J., Kang, R., Klionsky, D.J., Kroemer, G., and Tang, D. (2019). Ferroptosis is a type of autophagy-dependent cell death. Semin. Cancer Biol. pii: S1044-579X(19)30006-9. doi: 10.1016\/j.semcancer.2019.03.002.","DOI":"10.1016\/j.semcancer.2019.03.002"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_276_w2aab3b7c17b1b6b1ab2b1d276Aa","doi-asserted-by":"crossref","unstructured":"Zhu, X.C., Jiang, T., Zhang, Q.Q., Cao, L., Tan, M.S., Wang, H.F., Ding, Z.Z., Tan, L., and Yu, J.T. (2015). Chronic metformin preconditioning provides neuroprotection via suppression of NF-\u03baB-mediated inflammatory pathway in rats with permanent cerebral ischemia. Mol. Neurobiol. 52, 375\u2013385.","DOI":"10.1007\/s12035-014-8866-7"},{"key":"2022062616292444752_j_revneuro-2019-0072_ref_277_w2aab3b7c17b1b6b1ab2b1d277Aa","doi-asserted-by":"crossref","unstructured":"Zimbron, J., Khandaker, G.M., Toschi, C., Jones, P.B., and Fernandez-Egea, E. (2016). A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome. Eur. Neuropsychopharmacol. 26, 1353\u20131365.","DOI":"10.1016\/j.euroneuro.2016.07.010"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/revneuro\/31\/3\/article-p297.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0072\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0072\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T16:40:06Z","timestamp":1656261606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0072\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":277,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,11,20]]},"published-print":{"date-parts":[[2020,4,28]]}},"alternative-id":["10.1515\/revneuro-2019-0072"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2019-0072","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"value":"2191-0200","type":"electronic"},{"value":"0334-1763","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}